Buttress attachment features for surgical stapling apparatus

Information

  • Patent Grant
  • 10881395
  • Patent Number
    10,881,395
  • Date Filed
    Thursday, March 29, 2018
    6 years ago
  • Date Issued
    Tuesday, January 5, 2021
    3 years ago
Abstract
An end effector assembly for use with a surgical stapler, comprising a staple cartridge having a tissue contacting surface, an anvil plate having a tissue contacting surface, a buttress material releasably disposed on the tissue contacting surfaces of each of the staple cartridge and the anvil plate, and an epoxy positioned onto the tissue contacting surfaces of each of the staple cartridge and anvil plate defining an attachment zone configured to retain the respective buttress material atop the respective tissue contacting surfaces.
Description
BACKGROUND
1. Technical Field

The present disclosure relates to surgical stapling apparatuses and buttress materials for use with said surgical stapling apparatus and, more particularly, to structures and methods for attaching a buttress material to a surgical stapling apparatus.


2. Background of Related Art

Surgical stapling apparatus are employed by surgeons to sequentially or simultaneously apply one or more rows of fasteners, e.g., staples or two-part fasteners, to body tissue for the purpose of joining segments of body tissue together. Such apparatus generally include a pair of jaws or finger-like structures between which the body tissue to be joined is placed. When the stapling apparatus is actuated, or “fired”, longitudinally moving firing bars contact staple drive members in one of the jaws. The staple drive members push the surgical staples through the body tissue and into an anvil in the opposite jaw which forms the staples. If tissue is to be removed or separated, a knife blade can be provided in the jaws of the apparatus to cut the tissue between the lines of staples.


For most procedures, the use of bare staples, with the staples in direct contact with the patient's tissue, is generally acceptable. In certain procedures, the use of surgical supports, e.g., meshes or buttress materials, are employed by surgeons in combination with linear or annular stapling devices to bridge, repair and/or reinforce tissue defects within a patient, especially those occurring in the abdominal wall, chest wall, diaphragm, and other musculo-aponeurotic areas of the body. The buttress material tends to reinforce the staple or suture line as well as cover the juncture of the tissues to reduce leakage prior to healing. In certain minimally invasive surgical procedures the buttress material may be pre-attached to the surgical instrument being used. For example, the buttress material can be attached to a staple cartridge or anvil plate of a surgical stapling instrument by the manufacturer.


A surgical stapling apparatus having a surgical buttress releasably secured thereto by at least one anchor is disclosed in International Published Application No. WO 08/109125 A1, the disclosure of which is hereby incorporated by reference herein in its entirety. The buttress is attached to the apparatus by at least one anchor and includes knife blades for severing the anchors.


U.S. Pat. No. 5,441,193 to Gravener, the disclosure of which is hereby incorporated by reference herein in its entirety, discloses a surgical device having a sheet of curved resilient material attached thereto. Elongated projections can be fixed within slots using adhesive bonding and perforations permit tearing of the film to separate the central portion of the film from the side portions.


It would be desirable to provide improved means of securely attaching a surgical buttress to the staple cartridge or anvil plate while allowing the buttress material to fully release from the surgical stapling apparatus after the staples have been fired.


SUMMARY

Disclosed herein is a surgical stapling apparatus including a buttress material and a method of attaching the buttress material to the surgical stapling apparatus.


In one embodiment of present application a system for securing surgical buttresses to the jaws of the stapler is disclosed. The system allows the surgical buttresses to be secured to the staple cartridge and/or anvil plate by utilizing ultraviolet light curable epoxy to adhere the surgical buttresses to a tissue contacting surface of the staple cartridge and/or anvil plate. Perforations may be provided around the location of the epoxy to allow the surgical buttress to release from the tissue contacting surfaces by the force applied by the grasp of staples in the surgical buttress.


In accordance with one embodiment of the present disclosure, the use of ultraviolet light curable epoxy allows the same attachment means to be utilized for both the metal based anvil plate and metal or non-metal staple cartridge. In addition, the use of ultraviolet light curable epoxy can be precisely controlled both in terms of spatial placement and volume of deposition as to not impact the anvil plate or staple cartridge. Most importantly, the ultraviolet light curable epoxy is essentially part of the stapling device as it does not detach with the surgical material and is not implanted into the body.


In another embodiment of the present disclosure, surgical buttresses are secured to the staple cartridge and/or anvil plate with the use of retaining members placed through at least one hole of the surgical buttress and through at least one opening of at least one of the staple cartridge and/or anvil plate.


In one aspect of the present disclosure, a staple cartridge for use with a surgical stapling apparatus is disclosed. The staple cartridge includes a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots. The tissue contacting surface of the cartridge body is fabricated from a first material. The staple cartridge further includes a staple disposed within each staple retaining slot of the cartridge body. A buttress material is releasably disposed on the tissue contacting surface of the cartridge body and an epoxy is positioned on the tissue contacting surface of the cartridge body defining an attachment zone configured to retain the buttress material atop the tissue contacting surface.


In an aspect of the present disclosure, the epoxy is an ultraviolet light curable epoxy.


In an aspect of the present disclosure, the tissue contacting surface has a first and second outer edge.


In an aspect of the present disclosure, the tissue contacting surface has a distal end such that a distal attachment zone is positioned from the first outer edge to the second outer edge.


In an aspect of the present disclosure, the tissue contacting surface has a proximal end such that a first proximal attachment zone is positioned parallel to the first outer edge and second proximal attachment zone is positioned parallel to the second outer edge.


In an aspect of the present disclosure, the staple cartridge defines a central longitudinal slot configured to enable passage of a knife blade therethrough.


In an aspect of the present disclosure, the first and second proximal attachment zones are positioned distally from a proximal end of the central longitudinal slot.


In an aspect of the present disclosure, the distal attachment zone is positioned proximally for a distal end of the central longitudinal slot.


In an aspect of the present disclosure, the buttress material has perforations at the proximal end of the tissue contacting surface such that the perforations are positioned perpendicularly and distally from the first and second proximal attachment zone.


In an aspect of the present disclosure, the buttress material has perforations at the distal end of the tissue contacting surface such that the perforations are positioned parallel and proximal from the at least one distal attachment zone.


In an aspect of the present disclosure, a plurality of attachment zones are disposed intermittently along the first and second outer edges.


In an aspect of the present disclosure, the plurality of attachment zones are concentric.


In an aspect of the present disclosure, the buttress material has perforations such that the perforations surround the plurality of attachment zones.


In an aspect of the present disclosure, an end effector assembly for a surgical stapler is disclosed. The end effector including a staple cartridge having a tissue contacting surface, the tissue contacting surface of the cartridge body being fabricated from a first material. The end effector further including an anvil plate having a tissue contacting surface, the tissue contacting surface of the anvil plate being fabricated from a second material that is dissimilar from the first material. A buttress material is releasably disposed on the tissue contacting surfaces of each of the staple cartridge and the anvil plate and an epoxy positioned onto the tissue contacting surfaces of each of the staple cartridge and anvil plate defining an attachment zone configured to retain the respective buttress material atop the respective tissue contacting surfaces.


In an aspect of the present disclosure, a surgical stapling apparatus is disclosed. The apparatus includes a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots and a staple disposed with each staple retaining slot of the cartridge body. The staple cartridge further includes a substantially circular buttress material releasably disposed on the tissue contacting surface of the cartridge body, the buttress material including an inner peripheral edge, an outer peripheral edge, and a middle portion extending between the inner and outer peripheral edges and an epoxy positioned on the tissue contacting surface of the cartridge body defining an attachment zone configured to retain the buttress material atop the tissue contacting surface. In certain preferred embodiments, the epoxy is a curable epoxy, and may be curable upon exposure to ultraviolet light.


The buttress material may further include perforations arranged to allow the buttress material to separate from the cartridge body. A retaining member may also be disposed in a hole in the surgical stapling apparatus.


In a further aspect of the present disclosure, a method of assembling a surgical stapling apparatus comprises: providing a surgical stapling apparatus having at least one tissue contacting surface, the tissue contacting surface having a stapling zone and at least one attachment zone; applying epoxy on the at least one attachment zone on the tissue contacting surface; applying a buttress to the tissue contacting surface so as to contact at least a portion of the buttress with the epoxy, the buttress having a portion for overlying the stapling zone and a portion overlying the attachment zone for being permanently attached to the tissue contacting surface; and curing the epoxy.


The epoxy may be curable with exposure to ultraviolet light. In certain embodiments, the surgical stapling apparatus has an anvil plate and a staple cartridge. The surgical stapling apparatus can be selected from the group consisting of a circular surgical stapler and a linear surgical stapler. The method can include disposing a retaining member in a hole in the surgical stapling apparatus.


Any of the above aspects of the present disclosure described may be combined with any other aspect of the present disclosure without departing from the scope of the present disclosure.


In another aspect of the present disclosure, a tool assembly for use in a surgical stapling apparatus for joining tissue portions is disclosed. The tool assembly includes a staple cartridge containing a plurality of surgical staples therein and an anvil plate configured to cooperate with the staple cartridge to grasp tissue disposed therebetween where at least one of the staple cartridge and the anvil plate includes at least one opening. The tool assembly further includes a buttress material supported on the at least one of the staple cartridge and the anvil plate and including at least one hole formed therein. The tool assembly further includes at least one retaining member extending through the at least one hole and the at least one opening. The retaining member is configured to releasably secure the buttress material to the at least one of the staple cartridge and the anvil plate and is configured to separate from the buttress material to release the buttress material from the at least one of the staple cartridge and the anvil plate after firing of the surgical stapling apparatus.


In an aspect of the present disclosure, the at least one retaining member includes a pair of buttons and a tether extending therebetween. The tether extends through the at least one hole and the at least one opening with one of the buttons disposed adjacent each of the at least one hole and the at least one opening to releasably secure the buttress material to the at least one of the staple cartridge and the anvil plate.


In an aspect of the present disclosure, the pair of buttons are sized such that a diameter of each button is larger than the respective hole or opening.


In an aspect of the present disclosure, the at least one of the staple cartridge and the anvil plate includes a tissue contacting surface and a side surface. The buttress material includes a flap extending beyond the tissue contacting surface and configured for placement adjacent the side surface. The flap includes the at least one hole extending therethrough and the at least one opening is disposed in the side surface such that the at least one retaining member releasably secures the flap to the side surface.


In an aspect of the present disclosure, the surgical stapling apparatus is a linear surgical stapling apparatus.


In an aspect of the present disclosure, the at least one hole includes a plurality of holes longitudinally spaced along the buttress material.


In an aspect of the present disclosure, the at least one hole includes a plurality of holes spaced along the buttress material transverse to a longitudinal axis of the tool assembly.


In an aspect of the present disclosure, the at least one hole is disposed adjacent to a corner of the buttress material and the at least one opening extends through a tissue contacting surface of the at least one of the staple cartridge and the anvil plate.


In an aspect of the present disclosure, the surgical stapling apparatus is a circular surgical stapling apparatus.


In an aspect of the present disclosure, the at least one hole includes a plurality of holes annularly spaced along the buttress material.


In an aspect of the present disclosure, the buttress material includes a first flap adjacent an inner side surface of the at least one of the staple cartridge and the anvil plate and a second flap adjacent an outer surface of the at least one of the staple cartridge and the anvil plate. Each of the first and second flaps includes the at least one hole and each of the inner and outer side surfaces includes the at least one opening.


In an aspect of the present disclosure, a tissue contacting surface of the at least one of the staple cartridge and the anvil plate includes a flange extending radially inward therefrom. The buttress material is supported on the flange and includes the at least one hole adjacent the flange. The flange includes the at least one opening therein.


In an aspect of the present disclosure, the retaining member is formed of a bioabsorbable polymer.


In an aspect of the present disclosure, the retaining member is configured to fracture after the plurality of surgical fasteners are fired.


In an aspect of the present disclosure, the retaining member is dissolvable in a body fluid.


In an aspect of the present disclosure, the retaining member dissolvable in saline.


In an aspect of the present disclosure, the retaining member has a melt temperature of about body temperature.


In an aspect of the present disclosure, retaining member has a melt temperature of about 37° C.


In an aspect of the present disclosure, the buttress material includes a plurality of perforations that are configured to allow the retaining member to separate from the buttress material.


In yet another aspect of the present disclosure, a method of attaching a buttress material to a surgical stapling apparatus during assembly is disclosed. The method includes the steps of: providing a staple cartridge containing a plurality of surgical staples therein, providing an anvil plate configured to cooperate with the staple cartridge to grasp tissue disposed therebetween, positioning a buttress material on at least one of the staple cartridge and the anvil plate, inserting a retaining member having a first end and a second end through at least one hole of the buttress material and at least one opening of the at least one of the staple cartridge and the anvil plate, and melting the retaining member to form a button on each of the first and second ends to releasably secure the buttress material to the at least one of the staple cartridge and the anvil plate.


In an aspect of the present disclosure, the buttons are formed such that a diameter of each button is larger than the respective hole or opening.


In an aspect of the present disclosure, a surgical stapling apparatus for joining tissue portions is disclosed. The apparatus includes a staple cartridge having a plurality of surgical staples disposed therein and at least one opening formed therein. The staple cartridge further includes a buttress material supported on the staple cartridge and including at least one hole formed therein and at least one retaining member extending through the at least one hole and the at least one opening. The retaining member is configured to releasably secure the buttress material to the staple cartridge and is configured to separate from the buttress material to release the buttress material from the staple cartridge after firing of the surgical stapling apparatus.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments of the presently disclosed interlocking buttress retention systems are disclosed herein with reference to the drawings, wherein:



FIG. 1 is a perspective view of a surgical stapling apparatus according to an embodiment of the present disclosure;



FIG. 2 is a perspective view, with parts separated, of a staple cartridge of the surgical stapling apparatus of FIG. 1, illustrating a surgical buttress associated therewith;



FIG. 3 is a perspective view, with parts separated, of an anvil plate of the surgical stapling apparatus of FIG. 1, illustrating a surgical buttress associated therewith;



FIG. 4 is a perspective view of the staple cartridge, illustrating the surgical buttress affixed to the staple cartridge;



FIG. 5 is a perspective view of the anvil plate, illustrating the surgical buttress affixed to the anvil plate;



FIG. 6 is a perspective view of a distal end of the surgical stapling apparatus of FIG. 1, shown in use positioned about a tissue section;



FIG. 7 is a cross-sectional view taken along line 7-7 of FIG. 6;



FIG. 8 is a perspective view of the stapled and divided tissue section of FIG. 6;



FIG. 9A is a perspective view of an illustrative embodiment of a surgical stapling apparatus in accordance with another embodiment of the present disclosure;



FIG. 9B is a side elevational view partially, broken away, of the surgical stapling apparatus of FIG. 9A;



FIG. 10A is a perspective view of an illustrative embodiment of the staple cartridge of the surgical stapling apparatus of FIG. 9A including a surgical buttress in accordance with an embodiment of the present disclosure;



FIG. 10B is a top plan view of the staple cartridge and surgical buttress illustrated in FIG. 10A;



FIG. 11 is perspective view of an intestinal area of a patient, illustrating a method of positioning the anvil rod and staple cartridge of the surgical stapling apparatus of FIGS. 9A, 9B, and 10 within the intestinal area;



FIG. 12 is a schematic perspective view of the intestinal area of FIG. 11, illustrating the anvil rod mounted to the surgical stapling apparatus;



FIG. 13A is a perspective view of an alternate embodiment of a staple cartridge of the surgical stapling apparatus of FIG. 1, illustrating a buttress material supported thereon;



FIG. 13B is a top, plan view of the buttress material of FIG. 13A, illustrating the buttress material unfolded;



FIG. 14A is a top, cross-sectional view of the cartridge of FIG. 13A, taken along section line 14A-14A of FIG. 13A;



FIG. 14B is a front, cross-sectional view of the staple cartridge of FIG. 13A, taken along section line 14B-14B of FIG. 13A;



FIG. 15A is a perspective view of another embodiment of a staple cartridge of the annular surgical stapling apparatus of FIG. 1, illustrating a buttress material supported thereon;



FIG. 15B is a top, plan view the buttress material of FIG. 15A;



FIG. 16A is a side, cross-sectional view of the staple cartridge of FIG. 15A, taken along section line 16A-16A of FIG. 15A;



FIG. 16B is a front, cross-sectional view of the staple cartridge of FIG. 15A, taken along section line 16B-16B of FIG. 15A;



FIG. 17A is a perspective view of another embodiment of a staple cartridge of the annular surgical stapling apparatus of FIGS. 9A-9B, illustrating a buttress material supported thereon;



FIG. 17B is a top, plan view the buttress material of FIG. 17A, illustrating the buttress material unfolded;



FIG. 18A is a side, cross-sectional view of the staple cartridge of FIG. 17A, taken along section line 18A-18A of FIG. 17A;



FIG. 18B is a top, cross-sectional view of the staple cartridge of FIG. 17A, taken along section line 18B-18B of FIG. 17A;



FIG. 19A is a top, plan view of another embodiment of a staple cartridge of the annular surgical stapling apparatus of FIGS. 9A-9B, illustrating a buttress material supported on a flange of the staple cartridge;



FIG. 19B is a top, plan view the buttress material of FIG. 19A;



FIG. 20A is a side, cross-sectional view of the staple cartridge of FIG. 19A, taken along section line 20A-20A of FIG. 19A, illustrating the staple cartridge having a flange;



FIG. 20B is a side, cross-sectional view of another embodiment of a staple cartridge of FIG. 19A, illustrating the staple cartridge having a relatively wider inner surface;



FIG. 21 is a perspective view of a anvil plate of the surgical stapling apparatus of FIG. 1, illustrating a buttress material supported thereon in accordance with another embodiment of the present disclosure; and



FIG. 22 is a perspective view of a staple cartridge of the annular surgical stapling apparatus of FIGS. 9A-9B, illustrating a buttress material supported thereon in accordance with another embodiment of the present disclosure.





DETAILED DESCRIPTION OF THE EMBODIMENTS

Various exemplary embodiments of the present disclosure are discussed herein below in terms of buttresses for use with surgical stapling apparatus. The buttresses described herein may be used in sealing a wound by approximating the edges of wound tissue between a staple cartridge and an anvil plate of a surgical stapling apparatus which contains at least one buttress. The at least one buttress is joined to the surgical stapling apparatus by at least one attachment zone formed by an epoxy positioned between a tissue contacting surface of each of the staple cartridge and anvil plate and the least one buttress. Firing of the surgical stapling apparatus forces legs of at least one staple to pass through an opening on the staple cartridge, the tissue, and the openings on the anvil plate to secure the buttress to the tissue, to secure the adjoining tissue to one another, and to seal the tissue. Thus, the present disclosure describes surgical buttresses, surgical stapling apparatus supporting said surgical buttresses, and methods and mechanisms for using the same.


It should be understood that a variety of surgical stapling apparatus may be utilized with a surgical buttress of the present disclosure. For example, linear stapler configurations may be utilized, such as, for example those including Duet TRS' reloads and staplers with Tri-Staple™ technology, available through Covidien, which maintain a principal place of business at 555 Long Wharf Drive, North Haven, Conn. 06511, and transverse anastomosis staplers, such as, for example, EEA™, CEEA™, GIA™, EndoGIA™, and TA™ surgical staplers, also available through Covidien. It should also be appreciated that the principles of the present disclosure are equally applicable to surgical staplers having alternate configurations, such as, for example, end-to-end anastomosis staplers having a circular cartridge and anvil (see, e.g., commonly owned U.S. Pat. No. 5,915,616, entitled “Surgical Fastener Applying Apparatus,” the entire content of which is incorporated herein by this reference); laparoscopic staplers (see, e.g., commonly owned U.S. Pat. Nos. 6,330,965 and 6,241,139, each entitled “Surgical Stapling Apparatus,” the entire contents of each of which being incorporated herein by this reference); and transverse anastomosis staplers (see, e.g., commonly owned U.S. Pat. Nos. 5,964,394 and 7,334,717, each entitled “Surgical Fastener Applying Apparatus”, the entire contents of each of which being incorporated herein by this reference).


Embodiments of the presently disclosed surgical buttress and surgical stapling apparatus will now be described in detail with reference to the drawing figures wherein like reference numerals identify similar or identical elements. In the following discussion, the terms “proximal” and “trailing” may be employed interchangeably, and should be understood as referring to the portion of a structure that is closer to a clinician during proper use. The terms “distal” and “leading” may also be employed interchangeably, and should be understood as referring to the portion of a structure that is further from the clinician during proper use. As used herein, the term “patient” should be understood as referring to a human subject or other animal, and the term “clinician” should be understood as referring to a doctor, nurse, or other care provider and may include support personnel.


Referring now to FIG. 1, there is disclosed an exemplary surgical stapling apparatus or surgical stapler 10 for use in stapling tissue and applying a buttress material or surgical buttress to the tissue. An exemplary example of this type of surgical stapling instrument is disclosed in U.S. Pat. No. 7,128,253, the entire disclosure of which is incorporated by reference herein.


Surgical stapling apparatus 10 generally includes a handle 12 having an elongate tubular member 14 extending distally from handle 12. An end effector assembly 16 is mounted on a distal end 18 of elongate tubular member 14. End effector assembly 16 includes a staple cartridge 200 configured to receive a cartridge body 32 therein and an anvil plate 300. End effector assembly 16 may be permanently affixed to elongate tubular member 14 or may be detachable and thus replaceable with a new end effector assembly 16. Anvil plate 300 is movably mounted on distal end 18 of jaw assembly 16 and is movable between an open position spaced apart from staple cartridge 200 to a closed position substantially adjacent staple cartridge 200. Anvil plate 300 is fabricated from a metal material, including and not limited to stainless steel, titanium, titanium alloy, and the like. At least a tissue contacting surface of staple cartridge 200 is fabricated from a material other than metal, including and not limited to plastic, thermoplastic, resin, polycarbonate, and the like.


Surgical stapling apparatus 10 further includes a trigger 33, as seen in FIG. 1, movably mounted on handle 12. Actuation of trigger 33 initially operates to move anvil plate 300 from the open to the closed position relative to staple cartridge 200 and subsequently actuates surgical stapling apparatus 10 to apply lines of staples to tissue. In order to properly orient end effector assembly 16 relative to the tissue to be stapled, surgical stapling apparatus 10 is additionally provided with a rotation knob 34 mounted on handle 12. Rotation of rotation knob 34 relative to handle 12 rotates elongate tubular member 14 and end effector assembly 16 relative to handle 12 so as to properly orient end effector assembly 16 relative to the tissue to be stapled.


A driver 36, as seen in FIGS. 6 and 7A, is provided to move anvil plate 300 between the open and closed positions relative to staple cartridge 200. Driver 36 moves through a longitudinal slot 338 (FIG. 3) formed in anvil plate 300. A knife 30 with knife blade 31 is associated with driver 36 to cut tissue captured between staple cartridge 200 and anvil plate 300 as driver 36 passes through slot 338. The driver may be configured as a beam with an upper portion that engages the anvil plate 300 and a lower portion that engages the channel that supports the staple cartridge 200. For example, U.S. Pat. No. 7,565,993 to Milliman et al., the disclosure of which is hereby incorporated by reference herein in its entirety, discloses an axial drive assembly 212 including an elongated drive beam 266 for approximating the anvil and staple cartridge to clamp tissue and fire staples therein. The stapling apparatus 10 can include such a beam, or other known structure. The staple cartridge 200 has staple receiving slots for retaining staples therein, whereas the anvil plate includes staple forming recesses. The driver forces the staples from the staple receiving slots and drives them into the staple forming recesses so that they are formed into a closed shape around tissue.


Reference may be made to commonly owned U.S. Pat. Nos. 5,915,616, 6,330,965, and 6,241,139, referenced above, for a detailed discussion of the construction and operation of an exemplary surgical stapling apparatus 10.


Staple cartridge 200 and/or anvil plate 300 may be provided with a surgical buttress 500. Surgical buttress 500 is provided to reinforce and seal the lines of staples applied to tissue by surgical stapling apparatus 10. Surgical buttress 500 may be configured into any shape, size, or dimension suitable to fit any surgical stapling, fastening, or firing apparatus.


Staple cartridge 200 is provided with a cartridge buttress 500a and anvil plate 300 is provided with an anvil buttress 500b in the manners described in more detail hereinbelow. The buttresses 500a, 500b may be made from any biocompatible natural or synthetic material. The material from which the buttresses 500a, 500b are formed may be bioabsorbable or non-bioabsorbable. It should be understood that any combination of natural, synthetic, bioabsorbable and non-bioabsorbable materials may be used to form the buttress material. The buttresses 500a, 500b may be porous or non-porous, combination of porous and non-porous layers. The non-porous buttresses 500a, 500b may be utilized to retard or prevent tissue ingrowth from surrounding tissues thereby acting as an adhesion barrier and preventing the formation of unwanted scar tissue.


Additional exemplary materials for surgical buttresses 500a, 500b for use with the surgical stapling devices disclosed herein are set forth in commonly assigned U.S. Pat. Nos. 5,542,594; 5,908,427; 5,964,774; and 6,045,560, and commonly assigned U.S. Application Publication Nos. 2006/0085034, filed on Apr. 20, 2006; and 2006/0135992, filed on Jun. 22, 2006, the entire contents of each of being hereby incorporated herein by reference in their entirety.


As illustrated in the current embodiment and shown in FIGS. 2 and 3, surgical buttress 500 is releasably attached to staple cartridge 200 and/or anvil plate 300 at attachment zones 240, 340, respectively, defined by strategically positioned ultraviolet (UV) light curable epoxy that affixes surgical buttresses 500a, 500b to the inwardly facing or tissue contacting surfaces 220, 320 of the staple cartridge 200 and/or the anvil plate 300, as discussed in detail below. The use of UV curably epoxy enables fixing of surgical buttresses 500a, 500b to the respective tissue contacting surfaces 220, 320 of staple cartridge 200 and anvil plate 300 which are fabricated from dissimilar material.


With reference to FIG. 2, cartridge buttress 500a of staple cartridge 200 is operatively secured or adhered to a tissue contacting surface 220 of staple cartridge 200, by epoxy 250 positioned onto both a proximal end 260 and a distal end 262 of the tissue contacting surface 220. Epoxy 250 is disposed between the cartridge buttress 500a and the tissue contacting surface 220. Staple cartridge 200 further includes a first outer edge 248a and second outer edge 248b. A distal attachment zone 240a (FIG. 4) is disposed distally of a distal end of a central longitudinal slot 238 and extends substantially from the first outer edge 248a to the second outer edge 248b of staple cartridge 200. At least one proximal attachment zone 240b is disposed proximally of the distal end of the central longitudinal slot 238. The proximal and distal attachment zones on the staple cartridge are positioned outside the area in which the staple receiving slots are defined in the staple cartridge.


Cartridge buttress 500a includes perforations 246 that allow cartridge buttress 500a to be released from the tissue contacting surface 220. Perforations 246 extend linearly in a direction perpendicular to the central longitudinal slot 238 near the proximal and distal attachment zones 240a, 240b. In particular, at the distal end 262 of staple cartridge 200, perforations 246a of the cartridge buttress 500a are disposed between the distal attachment zone 240a and the distal end of the central longitudinal slot 238. Further, at the proximal end 260 of staple cartridge 200, the perforations 246b of the cartridge buttress 500a are disposed distally of each proximal attachment zone 240b.


With reference to FIG. 3, and similar to cartridge buttress 500a, anvil buttress 500b is operatively secured or adhered to a tissue contacting surface 320 of anvil plate 300, by epoxy 350 positioned at a proximal 360 and distal end 362 of the anvil plate 300 and between the anvil buttress 500b and the tissue contacting surface 320 of anvil plate 300. A distal attachment zone 340a (FIG. 5) is disposed distally of a distal end of a central longitudinal slot 338 and extends substantially between the outer edges 348a, 348b of anvil plate 300. At least one proximal attachment zone 342b is disposed proximally of the distal end of the central longitudinal slot 338. The proximal and distal attachment zones on the anvil plate 300 are positioned outside the area in which the staple receiving recesses are defined in the anvil plate.


Anvil buttress 500b includes perforations 346 similar to cartridge buttress 500a. Perforations 346 of anvil buttress 500b extend linearly in a direction perpendicular to the central longitudinal slot 338 near the proximal and distal attachment zones 340a, 340b from the first and second outer edges 348a, 348b. In particular, at the distal end 362 of anvil plate 300, the perforations 346a of the anvil buttress 500b are disposed between the distal attachment zone 340a and the distal end of the central longitudinal slot 338. Further, at the proximal end 360 of anvil plate 300, the perforations 346b of the anvil buttress 500b are disposed distally of each proximal attachment zone 340b. the perforations enable the buttresses 500a, 500b to be permanently attached to the anvil plate and staple cartridge while allowing the release of the buttresses after stapling has been performed.



FIGS. 4 and 5 illustrate the buttresses 500a, 500b disposed on the staple cartridge 200 and anvil plate 300, respectively. As shown, additional attachment zones 240c, 340c, for respective staple cartridge 200 and anvil plate 300, are disposed along outer edges 248a, 248b, 348a, 348b of each of staple cartridge 200 and anvil plate 300. Perforations 246c, 346c surround the attachments zones 240c, 340c to allow buttresses 500a, 500b to be released from the tissue contacting surfaces 220, 320. The attachment zones 240c, 340c are shown as concentric but additional shapes and sizes may be contemplated. The attachment zones in any of the embodiments disclosed herein may have shapes that are circular, rectangular, oblong, etc., or any appropriate shape. Likewise, the epoxy material in any of the embodiments disclosed herein may have shapes that are circular, rectangular, oblong, etc., or any appropriate shape.


During assembly, epoxy 250, 350 is disposed at predetermined locations on tissue contacting surfaces 220, 320 of each of staple cartridge 200 and anvil plate 300 by known methods, such as spraying, dipping, blotting, dabbing, or similar known methods in the art. Once the buttresses 500a, 500b are placed onto each of the tissue contacting surfaces 220, 320 of staple cartridge 200 and anvil plate 300, respectively, an ultraviolet light is used to cure epoxy 250, 350 and bond buttresses 500a, 500b to the epoxy 250, 350 and thus to the tissue contacting surfaces 220, 320. In any of the embodiments disclosed herein, it is contemplated that the epoxy could be partially cured and then the buttress is adhered to the partially cured epoxy.


In any of the embodiments disclosed herein, the epoxy can be an epoxy that is cured using any electromagnetic radiation, including but not limited to ultraviolet light.


As illustrated in FIG. 6, during use of surgical stapling apparatus 10, the staple cartridge 200 and anvil plate 300, having surgical buttresses 500a, 500b loaded thereon (as described above) are positioned on either side of the surgical site. Tissue contacting surfaces 220, 320 of staple cartridge 200 and anvil plate 300 are positioned adjacent layers of tissue “T” to be fastened to one another.


As shown in FIG. 7, staple cartridge 22 includes surgical staples 50 positioned within the individual staple retaining slots 52. Staples 50 are of a conventional type and include a backspan 54 having a pair of legs 56 and 58 extending from backspan 54. Legs 56 and 58 terminate in tissue penetrating tips 60 and 62, respectively. Pushers 64 are located within staple retaining slots 52 and are positioned between staples 50 and the path of a drive bar 66.


Surgical stapling apparatus 10 is initially actuated by movement of trigger 33 relative to handle 12 (FIG. 1) causing driver 36 to move in the direction of arrow “A” (FIG. 6), and against sloped edge 21 of anvil plate 300 thereby causing anvil plate 300 to be moved to the closed position relative to staple cartridge 200. As drive bar 66 advances distally within staple cartridge 32, drive bar 66 urges pushers 64 upwardly against backspan 54 of staples 50 driving legs 56 and 58 of staples 50 through the cartridge buttresses 500a, tissue “T”, and anvil buttress 500b, towards staple forming pockets 68 in anvil plate 300. Tissue penetrating tips 60 and 62 of staple legs 56 and 58 are bent within staple forming pockets 68 in anvil plate 20 with backspan 54 securing surgical buttress 24 against tissue “T”. The buttresses 500a, 500b tear along the perforations 246, 346 thereby breaking the bonds formed by the epoxy 250, 350 and releasing the buttresses 500a, 500b from the tissue contacting surfaces 220, 320 of each of the staple cartridge 200 and anvil plate 300. In this manner, epoxy 250, 350 remains on the tissue contacting surfaces 220, 320 as the buttresses 500a, 500b detach. The epoxy is not implanted into the body but is removed with the stapling apparatus.


Upon full actuation of surgical stapling apparatus 10, a knife 30 associated with surgical stapling apparatus 10 and carried by driver 36 may be utilized to cut tissue “T”, as well as surgical buttresses 500a, 500b between the rows of now formed staples 50. Upon movement of anvil plate 300 to the open position spaced apart from staple cartridge 200, surgical buttresses 500a, 500b finish pulling away from tissue contacting surfaces 220, 320 from staple cartridge 200 and anvil plate 300 along the perforations 246, 346.


The resulting tissue “T”, divided and stapled closed with staples 50, is illustrated in FIG. 8. Specifically, surgical buttresses 500a, 500b are secured against tissue “T” by legs 56, 58 and backspans 54 of staples 50. Thus, surgical buttresses 500a, 500b are stapled to tissue “T” thereby sealing and reinforcing the staple lines created by staples 50.


Referring now to FIGS. 9A and 9B, an annular surgical stapling apparatus 110, for use with surgical buttresses 124 of the present disclosure, is shown. Surgical stapling apparatus 110 includes a handle assembly 112 having at least one pivotable actuating handle member 133, and an advancing member 135. Extending from handle member 112, there is provided a tubular body portion 114 which may be constructed so as to have a curved shape along its length. Body portion 114 terminates in a staple cartridge 122 which includes a pair of annular arrays of staple retaining slots 152 having a staple 150 disposed in each one of staple retaining slots 152. Positioned distally of staple cartridge 122 there is provided an anvil assembly 120 including an anvil member 121 and a shaft 123 operatively associated therewith for removably connecting anvil assembly 120 to a distal end portion of stapling apparatus 110.


Staple cartridge 122 may be fixedly connected to the distal end of tubular body portion 114 or may be configured to concentrically fit within the distal end of tubular body portion 114. Staple cartridge 122 includes a staple pusher 164 including a proximal portion having a generally frusto-conical shape and a distal portion defining two concentric rings of peripherally spaced fingers (not shown), each one of which is received within a respective staple retaining slot 152.


A knife 130, substantially in the form of an open cup with the rim thereof defining a knife blade 131, is disposed within staple cartridge 122 and mounted to a distal surface of a staple pusher 164. The knife 130 is disposed radially inward of the pair of annular arrays of staples 150. Accordingly, in use, as the staple pusher 164 is advanced, the knife 130 is also advanced axially outward.


As seen in FIG. 10A, a surgical buttress 124 is releasably attached to the staple cartridge 122 at attachment zones 140 defined by deposits of epoxy 150 disposed between the surgical buttress 124 and the tissue contacting surface 134 of the staple cartridge 122. As described herein above, epoxy 150 bonds the surgical buttress 124 to the tissue contacting surface 134. Perforations 146 surround each deposit of epoxy 150 to allow surgical buttress 124 to release from tissue contacting surface 134. Surgical buttress 124 is provided in an annular configuration and includes a central aperture 125 to receive shaft 123 of anvil assembly 120 therethrough. As illustrated, the attachment zones 140 are concentric in an annular configuration about an outer peripheral edge 162 and inner peripheral edge 160 of staple cartridge 122.


It is envisioned that the surgical buttress 124 may be additionally or alternatively attached or adhered to tissue contacting surface of anvil plate 121 in a manner similar to the surgical buttress 124 attached to staple cartridge 122.


As shown in FIG. 10B, surgical buttress 124 may be secured or adhered to the staple cartridge 122 along an inner portion or peripheral edge 160 and outer portion or peripheral edge 162 of surgical buttress 124. It is envisioned that other configurations may be utilized to retain the surgical buttress 124 to the staple cartridge 122, such as providing the attachment zones 140 along either the inner or outer annular row of staple retaining slots 152, or alternating the attachment zones 140 between the staple retaining slots 152, or among other arrangements within the purview of those skilled in the art.


Surgical stapling apparatus 110 and detachable anvil assembly 120 are used in an anastomosis procedure to effect joining of intestinal sections 50 and 52. The anastomosis procedure is typically performed using minimally invasive surgical techniques including laparoscopic means and instrumentation. At the point in the procedure shown in FIG. 11, a diseased intestinal section has been previously removed, anvil assembly 120 (optionally including a surgical buttress 124 thereon) has been applied to the operative site either through a surgical incision or transanally and positioned within intestinal section 52, and tubular body portion 114 of surgical stapling apparatus 110 (optionally including a surgical buttress 124 thereon) has been inserted transanally into intestinal section 50. Intestinal sections 50 and 52 are also shown temporarily secured about their respective components (e.g., shaft 123 of anvil assembly 120, and the distal end of tubular body portion 114) by conventional means such as a purse string suture “P”, as illustrated in FIG. 12.


Thereafter, the clinician maneuvers anvil assembly 120 until the proximal end of shaft 123 is inserted into the distal end of tubular body portion 114 of surgical stapling apparatus 110, wherein the mounting structure (not shown) within the distal end of tubular body portion 114 engages shaft 123 to effect the mounting. Anvil assembly 120 and tubular body portion 114 are then approximated to approximate intestinal sections 50, 52. Surgical stapling apparatus 110 is then fired. A knife (not shown) cuts the portion of tissue and surgical buttress 124 disposed radially inward of the knife, to complete the anastomosis. The anvil assembly 120 and staple cartridge 122 are opened, with surgical buttress 124 stapled to intestinal sections 50 and 52. Surgical buttress 124 tears away from the deposits of epoxy 150, along perforations 146.


With reference now to FIGS. 13A, 13B, 14A and 14B an alternate embodiment is shown wherein buttress material 1000 is disposed on the tissue contacting surface 2200 of staple cartridge 2000 by a pair of flaps 1020, or margins of material that are positioned adjacent side surfaces 2320 of staple cartridge 2000. Staple cartridge 2000 is similar to staple cartridge 200 discussed hereinabove having tissue contacting surface 2200 and a plurality of retention slots 2380 formed therein for retaining a plurality of staples or fasteners 2400 therein. Any of the embodiments disclosed herein can include the flaps or margins for attaching buttress material.


Buttress material 1000 is disposed on the tissue contacting surface 2200 of staple cartridge 2000 over the openings 2380a of retention slots 2380. Buttress material 1000 includes a pair of flaps 1020 positioned adjacent side surfaces 2320 of staple cartridge 2000 and includes at least one hole 1040 extending through each of flaps 1020. Each hole 1040 is longitudinally spaced apart from the next along the length of a respective flap 1020. Staple cartridge 2000 further includes at least one opening 2480 in each of side surfaces 2320 where each opening 2480 corresponds to a respective one of the holes 1040 of buttress material 1000. In one embodiment, when buttress material 1000 is disposed on tissue contacting surface 2200, holes 1040 of buttress material 1000 substantially align or are in registration with the corresponding openings 2480 of staple cartridge 2000.


With reference now to FIGS. 14A and 14B, a retaining member 1060 extends through each hole 1040 of buttress material 1000 and corresponding opening 2480 of staple cartridge 2000 to secure buttress material 1000 to staple cartridge 2000. Retaining member 1060 includes a pair of buttons 1080 linked together by a shaft or tether 1100. Tether 1100 extends through one of openings 2480 and the corresponding hole 1040 such that a first button 1080a is disposed adjacent an inner surface 2320a of staple cartridge 2000 and a second button 1080b is disposed adjacent an outer surface 1120 of buttress material 1000. Each button 1080 is sized to be larger than a respective opening 2480 or hole 1040 to inhibit removal of the retaining member 1060 from the opening 2480 and hole 1040 during use. The retaining member may have other shapes, including hooks, loops, or tabs. In certain embodiments, the retaining member has bulbous ends that facilitate snapping the retaining member through the holes 2480 and 1040.


Retaining members 1060 may be formed of a bio-compatible or bio absorbable material. In one embodiment, retaining members 1060 may be configured to be brittle and absorbable such that, upon firing of surgical stapling apparatus 10, retaining members 1060 are fractured to release buttress material 1000 from staple cartridge 2000. In another embodiment, retaining members 1060 may be dissolvable upon application of a subsequent fluid by the surgeon or by a surgical instrument, e.g. a saline fluid, during use in order to release buttress material 1000 from staple cartridge 2000. Retaining members 1060 may also or alternatively be dissolvable by body fluids in order to release buttress material 1000. In another embodiment, retaining members 1060 may be formed of an absorbable polymer or other similar low melt temperature material that is configured to melt or soften at body temperature, e.g., about 37° C., to release buttress material 1000 from staple cartridge 2000. In any of the embodiments disclosed herein, retaining members that are integrally formed with the buttress material may be used to attach the buttress to the anvil or staple cartridge of a stapling apparatus.


With reference now to FIGS. 15A, 15B, 16A and 16B, in another embodiment buttress material 2100 is disposed on the tissue contacting surface 2200 of staple cartridge 2000 over the openings 2380a of retention slots 2380. Buttress material 2100 includes a proximal end 2600 and a distal end 2620. Each of proximal and distal ends 2600, 2620 includes at least one hole 2060 and preferably two holes 2060 extending therethrough. For example, in one embodiment, buttress material 2100 may be substantially rectangular with each hole 2060 disposed proximate to a corner 2080 of buttress material 2100. Staple cartridge 2000 further includes at least one opening 2050 through tissue contacting surface 2200 where each opening 2050 corresponds to a respective one of the holes 2060 of buttress material 2100. In one embodiment, when buttress material 2100 is disposed on tissue contacting surface 2200, holes 2060 of buttress material 2100 substantially align or are in registration with the corresponding openings 2050 of staple cartridge 2000.


With reference now to FIGS. 16A and 16B, one of retaining members 1060 extends through each hole 2060 of buttress material 2100 and corresponding opening 2050 of staple cartridge 2000 to secure buttress material 2100 to staple cartridge 2000, as described above. For example, tether 1100 of retaining member 1060 extends through one of openings 2050 and the corresponding hole 2060 such that the first button 1080a is disposed adjacent an inner surface 2200a of tissue contacting surface 2200 and the second button 1080b is disposed adjacent an outer surface 2010 of buttress material 2100. Each button 1080 is sized to be larger than a respective opening 2050 or hole 2060 to inhibit removal of the retaining member 1060 from the opening 2050 or hole 2060 during use.


It is contemplated that a buttress material 1000 or 2100 may also or alternatively be disposed on anvil assembly in the same manner as described above with regard to the attachment of buttress materials 1000 and 2100 to staple cartridge 2000.


With reference now to FIGS. 17A-20B buttress material is shown as generally annular in shape for securing to an annular surgical stapling apparatus 110 as discussed in FIGS. 9A and 9B. Referring now to FIGS. 17A, 17B, 18A and 18B, a buttress material 4000 is generally annular in shape and includes an inner portion 4020, a middle portion 4040, and an outer portion 4060. A substantially centrally located aperture 4080, defined by the inner circumference of inner portion 4020 is formed through buttress material 4000. Buttress material 4000 may be any shape sufficient to provide support for anastomosis of tissue after surgical stapling apparatus 110 has been fired including, for example, a square, a circle, an oval, a triangle or any other polygonal or other shape.


Buttress material 4000 is sized such that when buttress material 4000 is positioned over tissue contacting surface 3360 of staple cartridge 3200, buttress material 4000 extends radially beyond inner surface 3200a and outer surface 3200b of staple cartridge 3200 such that inner portion 4020 and outer portion 4060 of buttress material 4000 may be folded over to abut or engage inner and outer surfaces 3200a, 3200b, respectively.


Each of inner portion 4020 and outer portion 4060 includes an annular array of holes 4412, 4416, respectively, and inner and outer surfaces 3200a and 3200b include corresponding openings 3240, 3260, respectively for the reception of retaining members 1060 therethrough. For example, when buttress 4000 is positioned on tissue contacting surface 3360 with inner and outer portions 4020, 4060 folded over to abut inner and outer surfaces 3200a, 3200b, respectively, the holes 4120, 4160 and the corresponding openings 3240, 3260 may be substantially radially aligned or in registration.


With reference now to FIGS. 18A and 18B, one of retaining members 1060 extends through each hole 4120, 4160 of each of inner and outer portions 4020, 4060, respectively and through the corresponding openings 3240, 3260 of staple cartridge 3200 to secure buttress material 4000 to staple cartridge 3200. For example, the tether 1100 of a respective retaining member 1060 extends through one of openings 3240 of inner surface 3200a and through the corresponding hole 4120 of inner portion 4020 of buttress material 4000 such that the first button 1080a is disposed adjacent an inside portion 3250 of inner surface 3200a and the second button 1080b is disposed adjacent an outer surface 4020a of inner portion 4020 of buttress material 4000. Likewise, the tether 1100 of another retaining member 1060 extends through one of openings 3260 of outer surface 3200b and through the corresponding hole 4120 of outer portion 4060 such that the first button 1080a is disposed adjacent an inside portion 3270 of outer surface 3200b and the second button 1080b is disposed adjacent an outer surface 4060a of outer portion 4060. Each button 1080 is sized to be larger than a respective opening 3240, 3260 or hole 4120, 4160 to inhibit removal of the retaining member 1060 from the opening 3240, 3260 or hole 4120, 4160 during use.


With reference now to FIGS. 19A, 19B, 20A and 20B, in one embodiment, a buttress material 5000, formed of similar materials to buttress material 4000, described above, is generally annular in shape and includes an inner portion 5020, a middle portion 5040, and an outer portion 5060. A substantially centrally located aperture 5080, defined by the inner circumference of inner portion 5020 is formed through buttress material 5000. Buttress material 5000 may be any shape sufficient to provide support for anastomosis of tissue after surgical stapling apparatus 110 has been fired including, for example, a square, a circle, an oval, a triangle or any other polygonal or other shape.


With reference now to FIGS. 19A, 19B, and 20A, in one embodiment, buttress material 5000 is sized such that when buttress material 5000 is positioned over tissue contacting surface 3360 of staple cartridge 3200, the outer edge 5060a of outer portion 5060 of buttress material 5000 is substantially aligned with outer surface 3200b of staple cartridge 3200 and inner edge 5020a of inner portion 5020 extends radially inward of the inner surface 3200a of staple cartridge 3200. Staple cartridge 3200 includes a flange 3480 extending radially inward from tissue contacting surface 3360. Inner portion 5020 of buttress material 5000 includes an annular array of holes 5100, and flange 3480 includes a corresponding annular array of openings 3500 for the reception of retaining members 1060 therethrough. For example, when buttress 5000 is positioned on tissue contacting surface 3360 with inner portion 5020 extending radially inward of inner surface 3200a, inner portion 5020 is positioned on flange 3480 and the holes 5100 and the corresponding openings 3500 in flange 3480 may be substantially aligned or in registration, e.g., longitudinally aligned.


One of retaining members 1060 extends through each hole 5100 of inner portion 5020 and through the corresponding openings 3500 of flange 3480 to secure buttress material 5000 to staple cartridge 3200. For example, the tether 1100 of a respective retaining member 1060 extends through one of openings 3500 of flange 3480 and through the corresponding hole 5100 of inner portion 5020 of buttress material 5000 such that the first button 1080a is disposed adjacent a proximal surface 3480a of flange 3480 and the second button 1080b is disposed adjacent a distal surface 5020a of inner portion 5020 of buttress material 5000. Each button 1080 is sized to be larger than a respective opening 3500 or hole 5100 to inhibit removal of the retaining member 106 from the opening 3500 or hole 5100 during use.


With reference now to FIG. 20B, in another embodiment, staple cartridge 3200 may include an inner surface 3520 having a greater radial thickness than inner surface 3200a of staple cartridge 3200 illustrated in FIG. 20A such that a distal portion 3520a of inner surface 3520 of staple cartridge 3200 extends radially inward from tissue contacting surface 3360. Similar to flange 3480 above, distal portion 3520a of inner surface 3520 of staple cartridge 3200 includes an annular array of openings 3540 corresponding to the holes 5100 of buttress material 5000. For example, when buttress 5000 is positioned on tissue contacting surface 3360, inner portion 5020 is positioned on the distal portion 3520a of inner surface 3520 such that the holes 5100 and the corresponding openings 3540 may be substantially aligned, e.g., longitudinally aligned or in registration.


One of retaining members 1060 extends through each hole 5100 of inner portion 5020 of buttress material 5000 and through the corresponding openings 3540 of the distal portion 3520a of the inner surface 3520 of staple cartridge 3200 to secure buttress material 5000 to staple cartridge 3200. For example, the tether 1100 of a respective retaining member 1060 extends through one of openings 3540 of the distal portion 3520a of inner surface 3520 of staple cartridge 3200 and through the corresponding hole 5100 of inner portion 5020 of buttress material 5000 such that the first button 1080a is disposed proximal of the opening 3540 in distal portion 3520a and the second button 1080b is disposed adjacent a distal surface 5020a of inner portion 5020 of buttress material 5000. Each button 1080 is sized to be larger than a respective opening 3540 or hole 5100 to inhibit removal of the retaining member 1060 from the opening 3540 or hole 5080 during use.


Referring now to FIGS. 13A, 15A, 17A and 19A, in any of the above embodiments, buttress materials 1000, 2100, 4000 and 5000 may include perforations or breakaway sections 1140, 2140, 4140, 5140 that are configured to release the buttress material 1000, 2100, 4000, 5000 from the cartridge assemblies 2000, 3200. For example, buttress material 1000 may include perforations extending longitudinally along the fold line of flaps 1020, buttress material 2100 may include perforations extending transverse to the longitudinal axis adjacent the holes 2060 of the proximal and distal portions 2600, 26200, buttress material 4000 may include perforations extending radially along the fold lines of one or both of inner portion 4020 and outer portion 4060, and buttress material 5000 may include an annular array of perforations disposed radially outward of holes 5100 relative to a longitudinal axis of the staple cartridge 3200. Alternatively, or in addition, each of holes 1040, 2060, 4120, 4160 and 5100 may include perforations or break away sections such that buttons 1080a, 1080b of a retaining member 1060 may break through or snap through holes 1040, 2060, 4120, 4160 and 5100 as buttress material 1000, 2100, 4000, 5000 is released from cartridge assemblies 2000, 3200.


Referring now to FIGS. 21 and 22, in one embodiment, it is contemplated that a buttress material 1000, 2100, 4000 and 5000 may alternatively or additionally be removably secured to one of anvil assemblies 2202, and 3220 in a similar manner as described in the above embodiments for removable securement of buttress materials 1000, 2100, 4000 and 5000 to cartridge assemblies 2000 and 3200.


In one embodiment, retaining members 1060 may be formed during assembly of the surgical stapling apparatus or placement of buttress material to the surgical stapling apparatus 10, 110 during the manufacture or assembly thereof. In a method of attaching the buttress material to a surgical stapling apparatus, the polymer is deposited onto the buttress material, the polymer material having a melting temperature lower than the melting temperature of the buttress material. The polymer can be deposited by injection molding, spraying, dipping, or other methods. In this way, the polymer material can be melted without disrupting the physical properties of the buttress material. In an embodiment of the present disclosure, the degradable polymer material for the attachment features is the polymer used in making Caprosyn™ sutures, also known as L25, which has a melt temperature of about 125 to about 145 degrees celcius, while the buttress material is L41 or L21, which have melting temperatures of about 210 to about 220 degrees celcius and about 185 to about 200 degrees celcius respectively. The L21 polymer is used to make Maxon™ sutures. The polymer L41 is similar to L21, but has a different chemical structure, and has a greater degree of crystallinity and a higher glass transition temperature and melting temperature. Both L21 and L41 are a copolymer of glycolide and trimethylene carbonate.


In certain embodiments, the top of the driver 36 mechanically disrupts the interlocking features of the bonding polymer and may shear off a portion of the polymer material. In certain embodiments, the knife severs off a portion of the polymer material that attaches the buttress material to the apparatus. In certain embodiments, small pushers are provided in the staple cartridge, which are actuated along with the staple firing pushers, to release the buttress material from the apparatus. In further embodiments, additional cutting assemblies can be provided in the anvil, staple cartridge, or both.


In any of the embodiments disclosed herein, the buttress material or the polymer of the attachment zone or attachment feature can be made from glycolic acid, glycolide, lactic acid, lactide, dioxanone, epsilon-caprolactone, trimethylene carbonate, etc., as is known in the art.


Persons skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying figures are non-limiting exemplary embodiments, and that the description, disclosure, and figures should be construed merely exemplary of particular embodiments. It is to be understood, therefore, that the present disclosure is not limited to the precise embodiments described, and that various other changes and modifications may be effected by one skilled in the art without departing from the scope or spirit of the disclosure. Additionally, it is envisioned that the elements and features illustrated or described in connection with one exemplary embodiment may be combined with the elements and features of another exemplary embodiment without departing from the scope of the present disclosure, and that such modifications and variations are also intended to be included within the scope of the present disclosure. Accordingly, the subject matter of the present disclosure is not to be limited by what has been particularly shown and described, except as indicated by the appended claims.

Claims
  • 1. A staple cartridge for use with a surgical stapling apparatus, comprising: a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots therein, and first and second side surfaces defining respective first and second openings therethrough;a buttress material including a body portion overlying the tissue contacting surface of the cartridge body, and first and second flaps extending from the body portion and positioned adjacent to the respective first and second side surfaces of the cartridge body;a first retaining member including a shaft extending through the first opening of the first side surface of the cartridge body and through the first flap of the buttress material to releasably retain the buttress material to the cartridge body, the first retaining member including a first button disposed on a first end of the shaft and a second button disposed on a second end of the shaft, the first button positioned adjacent to an inner surface of the first side surface of the cartridge body and the second button positioned adjacent to an outer surface of the first flap of the buttress material, each of the first and second buttons having a diameter larger than a diameter of the shaft; anda second retaining member including a shaft extending through the second opening of the second side surface of the cartridge body and through the second flap of the buttress material to releasably retain the buttress material to the cartridge body, the second retaining member including a respective first button disposed on a first end of the shaft and a respective second button disposed on a second end of the shaft, the first button positioned adjacent to an inner surface of the second side surface of the cartridge body and the second button positioned adjacent to an outer surface of the second flap of the buttress material, each of the first and second buttons of the second retainer member having a diameter larger than a diameter of the shaft.
  • 2. The staple cartridge of claim 1, wherein the first flap of the buttress material includes a first hole in registration with the first opening of the first side surface of the cartridge body, and the second flap includes a second hole in registration with the second opening of the second side surface of the cartridge body, the first and second retaining members extending through the respective first and second holes of the buttress material.
  • 3. The staple cartridge of claim 1, wherein the first buttons of the first and second retaining members are larger in size than the respective first and second openings of the cartridge body.
  • 4. The staple cartridge of claim 1, wherein the first and second retaining members are bioabsorbable.
  • 5. The staple cartridge of claim 1, wherein the first and second retaining members are dissolvable.
  • 6. The staple cartridge of claim 1, wherein the first and second retaining members are frangible.
  • 7. The staple cartridge of claim 1, wherein the buttress material includes perforations disposed between the body portion and the first and second flaps along fold lines of the buttress material.
  • 8. The staple cartridge of claim 2, wherein the first and second holes of the buttress material include perforations.
  • 9. The staple cartridge of claim 1, wherein the first and second openings defined in the respective first and second side surfaces of the cartridge body are one of a plurality of first and second openings, and the first and second retaining members are one of a plurality of first and second retaining members.
  • 10. The staple cartridge of claim 1, wherein the cartridge body is a linear and the first and second side surfaces extend longitudinally along a length of the cartridge body on opposed sides of the tissue contacting surface.
  • 11. The staple cartridge of claim 1, wherein the cartridge body is annular and defines a centrally located aperture therein, and the first and second sides of the cartridge body are inner and outer surfaces of the cartridge body.
  • 12. A staple cartridge for use with a surgical stapling apparatus, comprising: a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots therein, the tissue contacting surface including proximal and distal portions defining respective first and second openings therethrough;a buttress material overlying the tissue contacting surface of the cartridge body; andfirst and second retaining members each including a shaft extending through the respective first and second openings of the cartridge body and through the buttress material to releasably retain the buttress material to the cartridge body, each of the first and second retaining members including a first button disposed on a first end of the respective shaft and a second button disposed on a second end of the respective shaft, the first button positioned adjacent to an inner surface of the tissue contacting surface of the cartridge body and the second button positioned adjacent to an outer surface of the buttress material, each of the first and second buttons of the first and second retaining members having a diameter larger than a diameter of the respective shaft.
  • 13. The staple cartridge of claim 12, wherein the buttress material includes first and second holes in registration with the first and second openings of the cartridge body, the first and second retaining members extending through the respective first and second holes of the buttress material.
  • 14. The staple cartridge of claim 12, wherein the first and second openings defined in the respective proximal and distal portions of the cartridge body are one of a plurality of first and second openings, and the first and second retaining members are one of a plurality of first and second retaining members.
  • 15. The staple cartridge of claim 12, wherein the diameters of the first buttons of the first and second retaining members are larger than diameters of the respective first and second openings of the cartridge body.
  • 16. The staple cartridge of claim 12, wherein each of the first buttons of the first and second retaining members is positioned directly against the inner surface of the tissue contacting surface of the cartridge body.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation application of U.S. patent application Ser. No. 13/942,822, filed on Jul. 16, 2013, which claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 61/684,846 filed on Aug. 20, 2012, the entire content of each of which is incorporated by reference herein.

US Referenced Citations (596)
Number Name Date Kind
3054406 Usher Sep 1962 A
3079606 Bobrov et al. Mar 1963 A
3124136 Usher Mar 1964 A
3364200 Ashton et al. Jan 1968 A
3490675 Green et al. Jan 1970 A
3499591 Green Mar 1970 A
3797494 Zaffaroni Mar 1974 A
3939068 Wendt et al. Feb 1976 A
3948666 Kitanishi et al. Apr 1976 A
4064062 Yurko Dec 1977 A
4166800 Fong Sep 1979 A
4282236 Broom Aug 1981 A
4347847 Usher Sep 1982 A
4354628 Green Oct 1982 A
4416698 McCorsley, III Nov 1983 A
4429695 Green Feb 1984 A
4452245 Usher Jun 1984 A
4605730 Shalaby et al. Aug 1986 A
4626253 Broadnax, Jr. Dec 1986 A
4655221 Devereux Apr 1987 A
4834090 Moore May 1989 A
4838884 Dumican et al. Jun 1989 A
4927640 Dahlinder et al. May 1990 A
4930674 Barak Jun 1990 A
5002551 Linsky et al. Mar 1991 A
5014899 Presty et al. May 1991 A
5040715 Green et al. Aug 1991 A
5057334 Vail Oct 1991 A
5065929 Schulze et al. Nov 1991 A
5112496 Dhawan et al. May 1992 A
5162430 Rhee et al. Nov 1992 A
5205459 Brinkerhoff et al. Apr 1993 A
5263629 Trumbull Nov 1993 A
5281197 Arias et al. Jan 1994 A
5307976 Olson et al. May 1994 A
5312023 Green et al. May 1994 A
5314471 Brauker et al. May 1994 A
5318221 Green et al. Jun 1994 A
5324775 Rhee et al. Jun 1994 A
5326013 Green et al. Jul 1994 A
5332142 Robinson et al. Jul 1994 A
5344454 Clarke et al. Sep 1994 A
5392979 Green et al. Feb 1995 A
5397324 Carroll et al. Mar 1995 A
5405072 Zlock et al. Apr 1995 A
5410016 Hubbell et al. Apr 1995 A
5425745 Green et al. Jun 1995 A
5441193 Gravener Aug 1995 A
5441507 Wilk Aug 1995 A
5443198 Viola et al. Aug 1995 A
5468253 Bezwada et al. Nov 1995 A
5484913 Stilwell et al. Jan 1996 A
5503638 Cooper et al. Apr 1996 A
5514379 Weissleder et al. May 1996 A
5542594 McKean et al. Aug 1996 A
5543441 Rhee et al. Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5550187 Rhee et al. Aug 1996 A
5575803 Cooper et al. Nov 1996 A
5645915 Kranzler et al. Jul 1997 A
5653756 Clarke et al. Aug 1997 A
5683809 Freeman et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5702409 Rayburn et al. Dec 1997 A
5752965 Francis et al. May 1998 A
5752974 Rhee et al. May 1998 A
5762256 Mastri et al. Jun 1998 A
5766188 Igaki Jun 1998 A
5769892 Kingwell Jun 1998 A
5782396 Mastri et al. Jul 1998 A
5799857 Robertson et al. Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5814057 Oi et al. Sep 1998 A
5819350 Wang Oct 1998 A
5833695 Yoon Nov 1998 A
5843096 Igaki et al. Dec 1998 A
5871135 Williamson, IV et al. Feb 1999 A
5874500 Rhee et al. Feb 1999 A
5895412 Tucker Apr 1999 A
5895415 Chow et al. Apr 1999 A
5902312 Frater May 1999 A
5908427 McKean Jun 1999 A
5915616 Viola et al. Jun 1999 A
5931847 Bittner et al. Aug 1999 A
5957363 Heck Sep 1999 A
5964394 Robertson Oct 1999 A
5964774 McKean et al. Oct 1999 A
5997895 Narotam et al. Dec 1999 A
6019791 Wood Feb 2000 A
6030392 Dakov Feb 2000 A
6032849 Mastri et al. Mar 2000 A
6045560 McKean et al. Apr 2000 A
6063097 Oi et al. May 2000 A
6080169 Turtel Jun 2000 A
6093557 Pui et al. Jul 2000 A
6099551 Gabbay Aug 2000 A
6142933 Longo et al. Nov 2000 A
6149667 Hovland et al. Nov 2000 A
6152943 Sawhney Nov 2000 A
6155265 Hammerslag Dec 2000 A
6156677 Brown Reed et al. Dec 2000 A
6165201 Sawhney et al. Dec 2000 A
6179862 Sawhney Jan 2001 B1
6210439 Firmin et al. Apr 2001 B1
6214020 Mulhauser et al. Apr 2001 B1
6241139 Milliman et al. Jun 2001 B1
6258107 Balazs et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6270530 Eldridge et al. Aug 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6299631 Shalaby Oct 2001 B1
6309569 Farrar et al. Oct 2001 B1
6312457 DiMatteo et al. Nov 2001 B1
6312474 Francis et al. Nov 2001 B1
6325810 Hamilton Dec 2001 B1
6330965 Milliman et al. Dec 2001 B1
6399362 Pui et al. Jun 2002 B1
6436030 Rehil Aug 2002 B2
6454780 Wallace Sep 2002 B1
6461368 Fogarty et al. Oct 2002 B2
6500777 Wiseman et al. Dec 2002 B1
6503257 Grant et al. Jan 2003 B2
6514283 DiMatteo et al. Feb 2003 B2
6514534 Sawhney Feb 2003 B1
6517566 Hovland et al. Feb 2003 B1
6551356 Rousseau Apr 2003 B2
6566406 Pathak et al. May 2003 B1
6568398 Cohen May 2003 B2
6590095 Schleicher et al. Jul 2003 B1
6592597 Grant et al. Jul 2003 B2
6605294 Sawhney Aug 2003 B2
6610006 Amid et al. Aug 2003 B1
6627749 Kumar Sep 2003 B1
6638285 Gabbay Oct 2003 B2
6652594 Francis et al. Nov 2003 B2
6656193 Grant et al. Dec 2003 B2
6656200 Li et al. Dec 2003 B2
6669735 Pelissier Dec 2003 B1
6673093 Sawhney Jan 2004 B1
6677258 Carroll et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6702828 Whayne Mar 2004 B2
6703047 Sawhney et al. Mar 2004 B2
6704210 Myers Mar 2004 B1
6723114 Shalaby Apr 2004 B2
6726706 Dominguez Apr 2004 B2
6736823 Darois et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6746458 Cloud Jun 2004 B1
6746869 Pui et al. Jun 2004 B2
6764720 Pui et al. Jul 2004 B2
6773458 Brauker et al. Aug 2004 B1
6818018 Sawhney Nov 2004 B1
6843252 Harrison et al. Jan 2005 B2
6896684 Monassevitch et al. May 2005 B2
6927315 Heinecke et al. Aug 2005 B1
6939358 Palacios et al. Sep 2005 B2
6946196 Foss Sep 2005 B2
6953139 Milliman et al. Oct 2005 B2
6959851 Heinrich Nov 2005 B2
7009034 Pathak et al. Mar 2006 B2
7025772 Gellman et al. Apr 2006 B2
7060087 DiMatteo et al. Jun 2006 B2
7087065 Ulmsten et al. Aug 2006 B2
7108701 Evens et al. Sep 2006 B2
7128253 Mastri et al. Oct 2006 B2
7128748 Mooradian et al. Oct 2006 B2
7134438 Makower et al. Nov 2006 B2
7141055 Abrams et al. Nov 2006 B2
7147138 Shelton, IV Dec 2006 B2
7160299 Baily Jan 2007 B2
7179268 Roy et al. Feb 2007 B2
7210810 Iversen et al. May 2007 B1
7214727 Kwon et al. May 2007 B2
7232449 Sharkawy et al. Jun 2007 B2
7241300 Sharkawy et al. Jul 2007 B2
7247338 Pui et al. Jul 2007 B2
7279322 Pui et al. Oct 2007 B2
7307031 Carroll et al. Dec 2007 B2
7308998 Mastri et al. Dec 2007 B2
7311720 Mueller et al. Dec 2007 B2
7328829 Arad et al. Feb 2008 B2
7334717 Rethy et al. Feb 2008 B2
7347850 Sawhney Mar 2008 B2
7377928 Zubik et al. May 2008 B2
7434717 Shelton, IV et al. Oct 2008 B2
7438209 Hess et al. Oct 2008 B1
7464849 Shelton, IV et al. Dec 2008 B2
7498063 Pui et al. Mar 2009 B2
7547312 Bauman et al. Jun 2009 B2
7559937 de la Torre et al. Jul 2009 B2
7565993 Milliman et al. Jul 2009 B2
7571845 Viola Aug 2009 B2
7592418 Pathak et al. Sep 2009 B2
7594921 Browning Sep 2009 B2
7595392 Kumar et al. Sep 2009 B2
7604151 Hess et al. Oct 2009 B2
7611494 Campbell et al. Nov 2009 B2
7635073 Heinrich Dec 2009 B2
7645874 Saferstein et al. Jan 2010 B2
7649089 Kumar et al. Jan 2010 B2
7655288 Bauman et al. Feb 2010 B2
7662409 Masters Feb 2010 B2
7662801 Kumar et al. Feb 2010 B2
7665646 Prommersberger Feb 2010 B2
7666198 Suyker et al. Feb 2010 B2
7669747 Weisenburgh, II et al. Mar 2010 B2
7673782 Hess et al. Mar 2010 B2
7708180 Murray et al. May 2010 B2
7709631 Harris et al. May 2010 B2
7717313 Criscuolo et al. May 2010 B2
7722642 Williamson, IV et al. May 2010 B2
7735703 Morgan et al. Jun 2010 B2
7744627 Orban, III et al. Jun 2010 B2
7754002 Maase et al. Jul 2010 B2
7776060 Mooradian et al. Aug 2010 B2
7789889 Zubik et al. Sep 2010 B2
7793813 Bettuchi Sep 2010 B2
7799026 Schechter et al. Sep 2010 B2
7823592 Bettuchi et al. Nov 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7845533 Marczyk et al. Dec 2010 B2
7845536 Viola et al. Dec 2010 B2
7846149 Jankowski Dec 2010 B2
7892247 Conston et al. Feb 2011 B2
7909224 Prommersberger Mar 2011 B2
7909837 Crews et al. Mar 2011 B2
7938307 Bettuchi May 2011 B2
7942890 D'Agostino et al. May 2011 B2
7950561 Aranyi May 2011 B2
7951166 Orban, III et al. May 2011 B2
7951248 Fallis et al. May 2011 B1
7967179 Olson et al. Jun 2011 B2
7988027 Olson et al. Aug 2011 B2
8011550 Aranyi et al. Sep 2011 B2
8011555 Tarinelli et al. Sep 2011 B2
8016177 Bettuchi et al. Sep 2011 B2
8016178 Olson et al. Sep 2011 B2
8025199 Whitman et al. Sep 2011 B2
8028883 Stopek Oct 2011 B2
8033483 Fortier et al. Oct 2011 B2
8033983 Chu et al. Oct 2011 B2
8038045 Bettuchi et al. Oct 2011 B2
8062330 Prommersberger et al. Nov 2011 B2
8062673 Figuly et al. Nov 2011 B2
8083119 Prommersberger Dec 2011 B2
8091756 Viola Jan 2012 B2
8123766 Bauman et al. Feb 2012 B2
8123767 Bauman et al. Feb 2012 B2
8127975 Olson et al. Mar 2012 B2
8133336 Kettlewell et al. Mar 2012 B2
8133559 Lee et al. Mar 2012 B2
8146791 Bettuchi et al. Apr 2012 B2
8152777 Campbell et al. Apr 2012 B2
8157149 Olson et al. Apr 2012 B2
8157151 Ingmanson et al. Apr 2012 B2
8167895 D'Agostino et al. May 2012 B2
8177797 Shimoji et al. May 2012 B2
8178746 Hildeberg et al. May 2012 B2
8192460 Orban, III et al. Jun 2012 B2
8201720 Hessler Jun 2012 B2
8210414 Bettuchi et al. Jul 2012 B2
8210453 Hull et al. Jul 2012 B2
8225799 Bettuchi Jul 2012 B2
8225981 Criscuolo et al. Jul 2012 B2
8231043 Tarinelli et al. Jul 2012 B2
8235273 Olson et al. Aug 2012 B2
8245901 Stopek Aug 2012 B2
8252339 Figuly et al. Aug 2012 B2
8252921 Vignon et al. Aug 2012 B2
8256654 Bettuchi et al. Sep 2012 B2
8257391 Orban, III et al. Sep 2012 B2
8276800 Bettuchi Oct 2012 B2
8286849 Bettuchi Oct 2012 B2
8308042 Aranyi Nov 2012 B2
8308045 Bettuchi et al. Nov 2012 B2
8308046 Prommersberger Nov 2012 B2
8312885 Bettuchi et al. Nov 2012 B2
8313014 Bettuchi Nov 2012 B2
8317790 Bell et al. Nov 2012 B2
8322590 Patel et al. Dec 2012 B2
8348126 Olson et al. Jan 2013 B2
8348130 Shah et al. Jan 2013 B2
8365972 Aranyi et al. Feb 2013 B2
8367089 Wan et al. Feb 2013 B2
8371491 Huitema et al. Feb 2013 B2
8371492 Aranyi et al. Feb 2013 B2
8371493 Aranyi et al. Feb 2013 B2
8372094 Bettuchi et al. Feb 2013 B2
8393514 Shelton, IV et al. Mar 2013 B2
8393517 Milo Mar 2013 B2
8408440 Olson et al. Apr 2013 B2
8408480 Hull et al. Apr 2013 B2
8413869 Heinrich Apr 2013 B2
8413871 Racenet et al. Apr 2013 B2
8418909 Kostrzewski Apr 2013 B2
8424742 Bettuchi Apr 2013 B2
8453652 Stopek Jun 2013 B2
8453904 Eskaros et al. Jun 2013 B2
8453909 Olson et al. Jun 2013 B2
8453910 Bettuchi et al. Jun 2013 B2
8464925 Hull et al. Jun 2013 B2
8470360 McKay Jun 2013 B2
8474677 Woodard, Jr. et al. Jul 2013 B2
8479968 Hodgkinson et al. Jul 2013 B2
8485414 Criscuolo et al. Jul 2013 B2
8496683 Prommersberger et al. Jul 2013 B2
8511533 Viola et al. Aug 2013 B2
8512402 Marczyk et al. Aug 2013 B2
8518440 Blaskovich et al. Aug 2013 B2
8529600 Woodard, Jr. et al. Sep 2013 B2
8540128 Shelton, IV et al. Sep 2013 B2
8540131 Swayze Sep 2013 B2
8551138 Orban, III et al. Oct 2013 B2
8556918 Bauman et al. Oct 2013 B2
8561873 Ingmanson et al. Oct 2013 B2
8579990 Priewe Nov 2013 B2
8584920 Hodgkinson Nov 2013 B2
8590762 Hess et al. Nov 2013 B2
8616430 (Prommersberger) Stopek et al. Dec 2013 B2
8617132 Golzarian et al. Dec 2013 B2
8631989 Aranyi et al. Jan 2014 B2
8646674 Schulte et al. Feb 2014 B2
8668129 Olson Mar 2014 B2
8678263 Viola Mar 2014 B2
8679137 Bauman et al. Mar 2014 B2
8684250 Bettuchi et al. Apr 2014 B2
8701958 Shelton, IV et al. Apr 2014 B2
8721703 Fowler May 2014 B2
8727197 Hess et al. May 2014 B2
8757466 Olson et al. Jun 2014 B2
8789737 Hodgkinson et al. Jul 2014 B2
8814888 Sgro Aug 2014 B2
8820606 Hodgkinson Sep 2014 B2
8827133 Shelton, IV et al. Sep 2014 B2
8857694 Shelton, IV et al. Oct 2014 B2
8864009 Shelton, IV et al. Oct 2014 B2
8870050 Hodgkinson Oct 2014 B2
8920443 Hiles et al. Dec 2014 B2
8920444 Hiles et al. Dec 2014 B2
8939344 Olson et al. Jan 2015 B2
8956390 Shah et al. Feb 2015 B2
8967448 Carter et al. Mar 2015 B2
9005243 Stopek et al. Apr 2015 B2
9010606 Aranyi et al. Apr 2015 B2
9010608 Casasanta, Jr. et al. Apr 2015 B2
9010609 Carter et al. Apr 2015 B2
9010610 Hodgkinson Apr 2015 B2
9010612 Stevenson et al. Apr 2015 B2
9016543 (Prommersberger) Stopek et al. Apr 2015 B2
9016544 Hodgkinson et al. Apr 2015 B2
9027817 Milliman et al. May 2015 B2
9044227 Shelton, IV et al. Jun 2015 B2
9055944 Hodgkinson et al. Jun 2015 B2
9084602 Gleiman Jul 2015 B2
9107665 Hodgkinson et al. Aug 2015 B2
9107667 Hodgkinson Aug 2015 B2
9113871 Milliman et al. Aug 2015 B2
9113873 Marczyk et al. Aug 2015 B2
9113885 Hodgkinson et al. Aug 2015 B2
9113893 Sorrentino et al. Aug 2015 B2
9161753 Prior Oct 2015 B2
9161757 Bettuchi Oct 2015 B2
9186140 Hiles et al. Nov 2015 B2
9186144 Stevenson et al. Nov 2015 B2
9192378 Aranyi et al. Nov 2015 B2
9192379 Aranyi et al. Nov 2015 B2
9192380 (Tarinelli) Racenet et al. Nov 2015 B2
9192383 Milliman Nov 2015 B2
9192384 Bettuchi Nov 2015 B2
9198660 Hodgkinson Dec 2015 B2
9198663 Marczyk et al. Dec 2015 B1
9204881 Penna Dec 2015 B2
9220504 Viola et al. Dec 2015 B2
9226754 D'Agostino et al. Jan 2016 B2
9237892 Hodgkinson Jan 2016 B2
9237893 Carter et al. Jan 2016 B2
9277922 Carter et al. Mar 2016 B2
9295466 Hodgkinson et al. Mar 2016 B2
9326768 Shelton, IV May 2016 B2
9326773 Casasanta, Jr. et al. May 2016 B2
9328111 Zhou et al. May 2016 B2
9345479 (Tarinelli) Racenet et al. May 2016 B2
9351729 Orban, III et al. May 2016 B2
9351731 Carter et al. May 2016 B2
9351732 Hodgkinson May 2016 B2
9358005 Shelton, IV et al. Jun 2016 B2
9364229 D'Agostino et al. Jun 2016 B2
9364234 (Prommersberger) Stopek et al. Jun 2016 B2
9386988 Baxter, III et al. Jul 2016 B2
9402627 Stevenson et al. Aug 2016 B2
9414839 Penna Aug 2016 B2
9433412 Bettuchi et al. Sep 2016 B2
9433413 Stopek Sep 2016 B2
9433420 Hodgkinson Sep 2016 B2
9445812 Olson et al. Sep 2016 B2
9445817 Bettuchi Sep 2016 B2
9463260 Stopek Oct 2016 B2
9486215 Olson et al. Nov 2016 B2
9492170 Bear et al. Nov 2016 B2
9504470 Milliman Nov 2016 B2
9517164 Vitaris et al. Dec 2016 B2
9572576 Hodgkinson et al. Feb 2017 B2
9585657 Shelton, IV et al. Mar 2017 B2
9597077 Hodgkinson Mar 2017 B2
9610080 Whitfield et al. Apr 2017 B2
9622745 Ingmanson et al. Apr 2017 B2
9629626 Soltz et al. Apr 2017 B2
9636850 Stopek et al. May 2017 B2
9655620 Prescott et al. May 2017 B2
9675351 Hodgkinson et al. Jun 2017 B2
9681936 Hodgkinson et al. Jun 2017 B2
9687262 Rousseau et al. Jun 2017 B2
9693772 Ingmanson et al. Jul 2017 B2
9708184 Chan et al. Jul 2017 B2
9770245 Swayze et al. Sep 2017 B2
9775617 Carter et al. Oct 2017 B2
9775618 Bettuchi et al. Oct 2017 B2
9782173 Mozdzierz Oct 2017 B2
9844378 Casasanta et al. Dec 2017 B2
9931116 Racenet et al. Apr 2018 B2
10022125 (Prommersberger) Stopek et al. Jul 2018 B2
10098639 Hodgkinson Oct 2018 B2
10111659 Racenet et al. Oct 2018 B2
10154840 Viola et al. Dec 2018 B2
20020091397 Chen Jul 2002 A1
20020151911 Gabbay Oct 2002 A1
20020165559 Grant Nov 2002 A1
20020165563 Grant Nov 2002 A1
20030065345 Weadock Apr 2003 A1
20030078209 Schmidt Apr 2003 A1
20030083676 Wallace May 2003 A1
20030125676 Swenson et al. Jul 2003 A1
20030181927 Wallace Sep 2003 A1
20030196668 Harrison et al. Oct 2003 A1
20030208231 Williamson et al. Nov 2003 A1
20040092912 Jinno et al. May 2004 A1
20040107006 Francis et al. Jun 2004 A1
20040131418 Budde et al. Jul 2004 A1
20040254590 Hoffman et al. Dec 2004 A1
20040260315 Dell et al. Dec 2004 A1
20050002981 Lahtinen et al. Jan 2005 A1
20050021085 Abrams et al. Jan 2005 A1
20050059996 Bauman Mar 2005 A1
20050059997 Bauman Mar 2005 A1
20050070929 Dalessandro et al. Mar 2005 A1
20050118435 DeLucia et al. Jun 2005 A1
20050149073 Arani et al. Jul 2005 A1
20050228446 Mooradian Oct 2005 A1
20050245965 Orban, III Nov 2005 A1
20050283256 Sommerich et al. Dec 2005 A1
20060004407 Hiles Jan 2006 A1
20060008505 Brandon Jan 2006 A1
20060025816 Shelton, IV Feb 2006 A1
20060085030 Bettuchi et al. Apr 2006 A1
20060085034 Bettuchi Apr 2006 A1
20060121266 Fandel et al. Jun 2006 A1
20060135992 Bettuchi Jun 2006 A1
20060173470 Oray et al. Aug 2006 A1
20060190027 Downey Aug 2006 A1
20060219752 Arad Oct 2006 A1
20070034669 de la Torre et al. Feb 2007 A1
20070203510 Bettuchi Aug 2007 A1
20070243227 Gertner Oct 2007 A1
20070246505 Pace-Floridia Oct 2007 A1
20080009811 Cantor Jan 2008 A1
20080029570 Shelton et al. Feb 2008 A1
20080082126 Murray et al. Apr 2008 A1
20080140115 Stopek Jun 2008 A1
20080169328 Shelton Jul 2008 A1
20080169332 Shelton et al. Jul 2008 A1
20080169333 Shelton et al. Jul 2008 A1
20080216855 Nasca Sep 2008 A1
20080220047 Sawhney et al. Sep 2008 A1
20080230583 Heinrich Sep 2008 A1
20080290134 Bettuchi Nov 2008 A1
20080308608 Prommersberger Dec 2008 A1
20080314960 Marczyk Dec 2008 A1
20090001121 Hess et al. Jan 2009 A1
20090001122 Prommersberger Jan 2009 A1
20090001130 Hess et al. Jan 2009 A1
20090031842 Kawai et al. Feb 2009 A1
20090095791 Eskaros et al. Apr 2009 A1
20090206125 Huitema Aug 2009 A1
20090206126 Huitema et al. Aug 2009 A1
20090206139 Hall et al. Aug 2009 A1
20090206141 Huitema et al. Aug 2009 A1
20090206142 Huitema et al. Aug 2009 A1
20090206143 Huitema Aug 2009 A1
20090218384 Aranyi Sep 2009 A1
20090277944 Dalessandro et al. Nov 2009 A9
20100016855 Ramstein et al. Jan 2010 A1
20100016888 Calabrese et al. Jan 2010 A1
20100065606 Stopek Mar 2010 A1
20100087840 Ebersole et al. Apr 2010 A1
20100116868 Prommersberger May 2010 A1
20100147921 Olson Jun 2010 A1
20100147922 Olson Jun 2010 A1
20100174253 Cline et al. Jul 2010 A1
20100203151 Hiraoka Aug 2010 A1
20100243707 Olson et al. Sep 2010 A1
20100243708 Aranyi Sep 2010 A1
20100264195 Bettuchi Oct 2010 A1
20100331859 Omori Dec 2010 A1
20100331880 Stopek Dec 2010 A1
20110034910 Ross et al. Feb 2011 A1
20110087279 Shah Apr 2011 A1
20110089220 Ingmanson et al. Apr 2011 A1
20110101070 Bettuchi et al. May 2011 A1
20110125138 Malinouskas et al. May 2011 A1
20110166673 Patel et al. Jul 2011 A1
20110233259 Olson Sep 2011 A1
20110278346 Hull Nov 2011 A1
20110278347 Olson et al. Nov 2011 A1
20110293690 Griffin et al. Dec 2011 A1
20120080336 Shelton, IV Apr 2012 A1
20120083723 Vitaris et al. Apr 2012 A1
20120145767 Shah et al. Jun 2012 A1
20120197272 Oray et al. Aug 2012 A1
20120241491 Aldridge et al. Sep 2012 A1
20120241492 Shelton, IV Sep 2012 A1
20120241493 Baxter, III et al. Sep 2012 A1
20120241497 Mandakolathur Vasudevan Sep 2012 A1
20120253298 Henderson et al. Oct 2012 A1
20120273547 Hodgkinson Nov 2012 A1
20130105548 Hodgkinson May 2013 A1
20130146642 Shelton, IV Jun 2013 A1
20130153635 Hodgkinson Jun 2013 A1
20130153636 Shelton, IV et al. Jun 2013 A1
20130153638 Carter Jun 2013 A1
20130153641 Shelton, IV et al. Jun 2013 A1
20130209659 Racenet et al. Aug 2013 A1
20130256380 Schmid et al. Oct 2013 A1
20140048580 Merchant et al. Feb 2014 A1
20140131418 Kostrzewski May 2014 A1
20140224686 Aronhalt et al. Aug 2014 A1
20140239047 Hodgkinson et al. Aug 2014 A1
20140252062 Mozdzierz Sep 2014 A1
20150001276 Hodgkinson et al. Jan 2015 A1
20150041347 Hodgkinson Feb 2015 A1
20150097018 Hodgkinson Apr 2015 A1
20150115015 Prescott et al. Apr 2015 A1
20150122872 Olson et al. May 2015 A1
20150133995 Shelton, IV et al. May 2015 A1
20150164503 Stevenson et al. Jun 2015 A1
20150164506 Carter et al. Jun 2015 A1
20150164507 Carter et al. Jun 2015 A1
20150196297 (Prommersberger) Stopek et al. Jul 2015 A1
20150209033 Hodgkinson Jul 2015 A1
20150209045 Hodgkinson et al. Jul 2015 A1
20150209048 Carter et al. Jul 2015 A1
20150231409 Racenet et al. Aug 2015 A1
20150305743 Casasanta et al. Oct 2015 A1
20150327864 Hodgkinson et al. Nov 2015 A1
20160022268 Prior Jan 2016 A1
20160045200 Milliman Feb 2016 A1
20160058451 Racenet et al. Mar 2016 A1
20160100834 Viola et al. Apr 2016 A1
20160106430 Carter et al. Apr 2016 A1
20160113647 Hodgkinson Apr 2016 A1
20160128694 Baxter, III et al. May 2016 A1
20160157857 Hodgkinson et al. Jun 2016 A1
20160174988 D'Agostino et al. Jun 2016 A1
20160206315 Olson Jul 2016 A1
20160220257 Casasanta Aug 2016 A1
20160249923 Hodgkinson et al. Sep 2016 A1
20160256166 (Prommersberger) Stopek et al. Sep 2016 A1
20160270793 Carter et al. Sep 2016 A1
20160310143 Bettuchi Oct 2016 A1
20160338704 Penna Nov 2016 A1
20160367252 Olson et al. Dec 2016 A1
20160367253 Hodgkinson Dec 2016 A1
20160367257 Stevenson et al. Dec 2016 A1
20170042540 Olson et al. Feb 2017 A1
20170049452 Milliman Feb 2017 A1
20170119390 Schellin et al. May 2017 A1
20170150967 Hodgkinson et al. Jun 2017 A1
20170172575 Hodgkinson Jun 2017 A1
20170231629 Stopek et al. Aug 2017 A1
20170238931 Prescott et al. Aug 2017 A1
20170281328 Hodgkinson et al. Oct 2017 A1
20170296188 Ingmanson et al. Oct 2017 A1
20170354415 Casasanta, Jr. et al. Dec 2017 A1
20180125491 Aranyi May 2018 A1
20180140301 Milliman May 2018 A1
20180168654 Hodgkinson et al. Jun 2018 A1
20180214147 Merchant et al. Aug 2018 A1
20180229054 Racenet et al. Aug 2018 A1
20180250000 Hodgkinson et al. Sep 2018 A1
20180256164 Aranyi Sep 2018 A1
20180296214 Hodgkinson et al. Oct 2018 A1
20180310937 (Prommersberger) Stopek et al. Nov 2018 A1
20190021734 Hodgkinson Jan 2019 A1
20190059878 (Tarinelli) Racenet et al. Feb 2019 A1
20190083087 Viola et al. Mar 2019 A1
Foreign Referenced Citations (36)
Number Date Country
2282761 Sep 1998 CA
101310680 Nov 2008 CN
101332110 Dec 2008 CN
1602563 Mar 1950 DE
19924311 Nov 2000 DE
0327022 Aug 1989 EP
0594148 Apr 1994 EP
2039308 Mar 2009 EP
2090252 Aug 2009 EP
2163211 Mar 2010 EP
2189121 May 2010 EP
2258282 Dec 2010 EP
2292276 Mar 2011 EP
2491867 Aug 2012 EP
2497431 Sep 2012 EP
2620105 Jul 2013 EP
2762091 Aug 2014 EP
2000166933 Jun 2000 JP
2002202213 Jul 2002 JP
2003000603 Jan 2003 JP
2003190178 Jul 2003 JP
2007124166 May 2007 JP
2008289883 Dec 2008 JP
2008307393 Dec 2008 JP
2009189847 Aug 2009 JP
2010142636 Jul 2010 JP
2010214132 Sep 2010 JP
9005489 May 1990 WO
9516221 Jun 1995 WO
9838923 Sep 1998 WO
9926826 Jun 1999 WO
0010456 Mar 2000 WO
0016684 Mar 2000 WO
2005079675 Sep 2005 WO
2008109125 Sep 2008 WO
2010075298 Jul 2010 WO
Non-Patent Literature Citations (177)
Entry
Extended European Search Report corresponding to Patent Application EP 12196912.5 dated Feb. 1, 2016.
Chinese Second Office Action corresponding to Patent Application CN 201610279682.3 dated Aug. 8, 2018.
Chinese Second Office Action corresponding to Patent Application CN 201410588811.8 dated Aug. 27, 2018.
Extended European Search Report corresponding to Patent Application EP 18160809.2 dated Sep. 18, 2018.
Extended European Search Report corresponding to Patent Application EP 18192317.8 dated Dec. 20, 2018.
Extended European Search Report corresponding to Patent Application EP 18190154.7 dated Feb. 4, 2019.
Extended European Search Report corresponding to EP 16 15 3647.9 dated Jun. 3, 2016.
Extended Office Action corresponding to counterpart Int'l Appln. No. EP 13 18 0881.8 dated Nov. 18, 2016.
European Office Action corresponding to EP 14 17 2681.0 dated May 13, 2016.
Chinese Office Action corresponding to CN 201210545228 dated Jun. 29, 2016.
Japanese Office Action corresponding to JP 2012-250058 dated Jun. 29, 2016.
European Office Action corresponding to EP 14 15 7997.9 dated Jun. 29, 2016.
Canadian Office Action corresponding to CA 2,712,617 dated Jun. 30, 2016.
Chinese First Office Action corresponding to CN 2013103036903 dated Jun. 30, 2016.
Australian Patent Examination Report No. 1 corresponding to AU 2012250278 dated Jul. 10, 2016.
Australian Patent Examination Report No. 1 corresponding to AU 2012244382 dated Jul. 10, 2016.
Japanese Office Action corresponding to 2012-255242 dated Jul. 26, 2016.
Japanese Office Action corresponding to JP 2012-268668 dated Jul. 27, 2016.
European Office Action corresponding to EP 14 15 2060.1 dated Aug. 4, 2016.
European Office Action corresponding to EP 12 16 5609.4 dated Aug. 5, 2016.
European Office Action corresponding to EP 15 15 2392.5 dated Aug. 8, 2016.
Japanese Office Action corresponding to JP 2013-003624 dated Aug. 25, 2016.
Australian Patent Examination Report No. 1 corresponding to AU 2012261752 dated Sep. 6, 2016.
Japanese Office Action corresponding to JP 2014-252703 dated Sep. 26, 2016.
European Office Action corresponding to EP 12 19 8776.2 dated Sep. 12, 2016.
Japanese Office Action corresponding to JP 2013-000321 dated Sep. 13, 2016.
Chinese Second Office Action corresponding to CN 201310353628.5 dated Sep. 26, 2016.
European Office Action corresponding to EP 12 15 2541.4 dated Sep. 27, 2016.
Australian Patent Examination Report No. 1 corresponding to AU 2012268923 dated Sep. 28, 2016.
Australian Examination Report No. 1 corresponding to AU 2013211499 dated May 4, 2017.
Chinese First Office Action corresponding to CN 2013107068710 dated Dec. 16, 2016.
Chinese First Office Action corresponding to CN 201310646606.8 dated Dec. 23, 2016.
Japanese Office Action corresponding to JP 2013-000321 dated Jan. 4, 2017.
Extended European Search Report corresponding to EP 16 16 6367.9 dated Jan. 16, 2017.
Australian Examination Report No. 1 corresponding to AU 2013206777 dated Feb. 1, 2017.
Chinese Second Office Action corresponding to CN 2013103036903 dated Feb. 23, 2017.
Japanese Office Action corresponding to JP 2013-175379 dated Mar. 1, 2017.
Chinese First Office Action corresponding to CN 201410028462.4 dated Mar. 2, 2017.
Chinese First Office Action corresponding to CN 201410084070 dated Mar. 13, 2017.
Extended European Search Report corresponding to EP 16 19 6549.6 dated Mar. 17, 2017.
Japanese Office Action corresponding to JP 2013-147701 dated Mar. 21, 2017.
Australian Examination Report No. 1 corresponding to AU 2013206804 dated Mar. 21, 2017.
Australian Examination Report No. 1 corresponding to AU 2014201008 dated May 23, 2017.
Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-169083 dated May 31, 2017.
European Office Action corresponding to EP 15 17 4146.9 dated May 15, 2017.
Japanese Office Action corresponding to JP 2013-154561 dated May 23, 2017.
European Office Action corresponding to EP 12 19 4784.0 dated May 29, 2017.
Japanese Office Action corresponding to JP 2013-169083 dated May 31, 2017.
Australian Examination Report No. 1 corresponding to AU 2013213767 dated Jun. 29, 2017.
Australian Examination Report No. 2 corresponding to AU 2012261752 dated Jul. 7, 2017.
Australian Examination Report No. 1 corresponding to AU 2013266989 dated Jul. 10, 2017.
Extended European Search Report corresponding to EP 14 15 3609.4 dated Jul. 14, 2017.
Australian Examination Report No. 1 corresponding to AU 2013234418 dated Jul. 14, 2017.
Extended European Search Report corresponding to EP 14 15 3610.2 dated Jul. 17, 2017.
Australian Examination Report No. 1 corresponding to AU 2014200109 dated Jul. 20, 2017.
Australian Examination Report No. 1 corresponding to AU 2014200074 dated Jul. 20, 2017.
Canadian Office Action dated Jul. 16, 2019 corresponding to counterpart Patent Application CA 2,823,283.
Japanese Office Action corresponding to JP 2013-250857 dated Aug. 17, 2017.
Japanese Office Action corresponding to JP 2013-229471 dated Aug. 17, 2017.
Australian Examination Report No. 1 corresponding to AU 2014200793 dated Sep. 2, 2017.
Extended European Search Report corresponding to EP 17 17 8528.0 dated Oct. 13, 2017.
Australian Examination Report No. 1 corresponding to AU 2013234420 dated Oct. 24, 2017.
Japanese Office Action corresponding to JP 2013-175379 dated Oct. 20, 2017.
Japanese Office Action corresponding to JP 2013-147701 dated Oct. 27, 2017.
Extended European Search Report corresponding to EP 17 17 5656.2 dated Nov. 7, 2017.
Japanese Office Action corresponding to JP 2014-009738 dated Nov. 14, 2017.
European Office Action corresponding to EP 13 17 3986.4 dated Nov. 29, 2017.
Japanese Office Action corresponding to JP 2017-075975 dated Dec. 4, 2017.
European Office Action corresponding to EP 13 19 7958.5 dated Dec. 11, 2017.
European Search Report corresponding to EP 06 00 4598, completed Jun. 22, 2006; (2 pp).
European Search Report corresponding to EP 06 01 6962.0, completed Jan. 3, 2007 and dated Jan. 11, 2007; (10 pp).
International Search Report corresponding to International Application No. PCT/US2005/036740, completed Feb. 20, 2007 and dated Mar. 23, 2007; (8 pp).
International Search Report corresponding to International Application No. PCT/US2007/022713, completed Apr. 21, 2008 and dated May 15, 2008; (1 p).
International Search Report corresponding to International Application No. PCT/US2008/002981, completed Jun. 9, 2008 and dated Jun. 26, 2008; (2 pp).
European Search Report corresponding to EP 08 25 1779, completed Jul. 14, 2008 and dated Jul. 23, 2008; (5 pp).
European Search Report corresponding to EP 08 25 1989.3, completed Mar. 11, 2010 and dated Mar. 24, 2010; (6 pp).
European Search Report corresponding to EP 10 25 0639.1, completed Jun. 17, 2010 and dated Jun. 28, 2010; (7 pp).
European Search Report corresponding to EP 10 25 0715.9, completed Jun. 30, 2010 and dated Jul. 20, 2010; (3 pp).
European Search Report corresponding to EP 05 80 4382.9, completed Oct. 5, 2010 and dated Oct. 12, 2010; (3 pp).
European Search Report corresponding to EP 09 25 2897.5, completed Feb. 7, 2011 and dated Feb. 15, 2011; (3 pp).
European Search Report corresponding to EP 10 25 0642.5, completed Mar. 25, 2011 and dated Apr. 4, 2011; (4 pp).
European Search Report corresponding to EP 12 15 2229.6, completed Feb. 23, 2012 and dated Mar. 1, 2012; (4 pp).
European Search Report corresponding to EP 12 15 0511.9, completed Apr. 16, 2012 and dated Apr. 24, 2012; (7 pp).
European Search Report corresponding to EP 12 15 2541.4, completed Apr. 23, 2012 and dated May 3, 2012; (10 pp).
European Search Report corresponding to EP 12 16 5609.4, completed Jul. 5, 2012 and dated Jul. 13, 2012; (8 pp).
European Search Report corresponding to EP 12 15 8861.0, completed Jul. 17, 2012 and dated Jul. 24, 2012; (9 pp).
European Search Report corresponding to EP 12 16 5878.5, completed Jul. 24, 2012 and dated Aug. 6, 2012; (8 pp).
Extended European Search Report corresponding to EP 12 19 1035.0, completed Jan. 11, 2013 and dated Jan. 18, 2013; (7 pp).
Extended European Search Report corresponding to EP 12 18 6175.1, completed Jan. 15, 2013 and dated Jan. 23, 2013; (7 pp).
Extended European Search Report corresponding to EP 12 19 1114.3, completed Jan. 23, 2013 and dated Jan. 31, 2013; (10 pp).
Extended European Search Report corresponding to EP 12 19 2224.9, completed Mar. 14, 2013 and dated Mar. 26, 2013; (8 pp).
Extended European Search Report corresponding to EP 12 19 6904.2, completed Mar. 28, 2013 and dated Jul. 26, 2013; (8 pp).
Extended European Search Report corresponding to EP 12 19 6911.7, completed Apr. 18, 2013 and dated Apr. 24, 2013; (8 pp).
Extended European Search Report corresponding to EP 07 00 5842.5, completed May 13, 2013 and dated May 29, 2013; (7 pp).
Extended European Search Report corresponding to EP 12 19 8776.2, completed May 16, 2013 and dated May 27, 2013; (8 pp).
Extended European Search Report corresponding to EP 12 19 8749.9, completed May 21, 2013 and dated May 31, 2013; (8 pp).
Extended European Search Report corresponding to EP 13 15 6297.7, completed Jun. 4, 2013 and dated Jun. 13, 2013; (7 pp).
Extended European Search Report corresponding to EP 13 17 3985.6, completed Aug. 19, 2013 and dated Aug. 28, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 17 3986.4, completed Aug. 20, 2013 and dated Aug. 29, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 17 7437.4, completed Sep. 11, 2013 and dated Sep. 19, 2013; 6 pages.
Extended European Search Report corresponding to EP 13 17 7441.6, completed Sep. 11, 2013 and dated Sep. 19, 2013; (6 pp).
Extended European Search Report corresponding to EP 07 86 1534.1, completed Sep. 20, 2013 and dated Sep. 30, 2013; (5 pp).
Extended European Search Report corresponding to EP 13 18 3876.5, completed Oct. 14, 2013 and dated Oct. 24, 2013; (5 pp).
Extended European Search Report corresponding to EP 13 17 1856.1, completed Oct. 29, 2013 and dated Nov. 7, 2013; (8 pp).
Extended European Search Report corresponding to EP 13 18 0373.6, completed Oct. 31, 2013 and dated Nov. 13, 2013; (7 pp).
Extended European Search Report corresponding to EP 13 18 0881.8, completed Nov. 5, 2013 and dated Nov. 14, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 17 6895.4, completed Nov. 29, 2013 and dated Dec. 12, 2013; (5 pp).
Extended European Search Report corresponding to EP 14 16 9739.1, completed Aug. 19, 2014 and Aug. 29, 2014; (7 pp).
Extended European Search Report corresponding to EP 14 15 7997.9, completed Sep. 9, 2014 and dated Sep. 17, 2014; (8 pp).
Extended European Search Report corresponding to EP 14 16 8904.2, completed Sep. 10, 2014 and dated Sep. 18, 2014; (8 pp).
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Oct. 13, 2014; (10 pp).
Extended European Search Report corresponding to EP 13 15 4571.7, completed Oct. 10, 2014 and dated Oct. 20, 2014; (8 pp).
Extended European Search Report corresponding to EP 14 18 1125.7, completed Oct. 16, 2014 and dated Oct. 24, 2014; (7 pp).
Extended European Search Report corresponding to EP 14 18 1127.3, completed Oct. 16, 2014 and dated Nov. 10, 2014; (8 pp).
Extended European Search Report corresponding to EP 14 19 0419.3, completed Mar. 24, 2015 and dated Mar. 30, 2015; (6 pp).
European Office Action corresponding to EP 13 180 881.8 dated Jun. 19, 2015; 4 pp.
European Office Action corresponding to EP 12 198 776.2 dated Apr. 7, 2015.
European Office Action corresponding to EP 13 156 297.7 dated Apr. 10, 2015.
Australian Examination Report No. 1 corresponding to AU 2011250822 dated May 18, 2015.
European Office Action corresponding to EP 12 186 175.1 dated Jun. 1, 2015.
Chinese Office Action corresponding to CN 201010517292.8 dated Jun. 2, 2015.
Extended European Search Report corresponding to EP 14 17 4814.5 dated Jun. 9, 2015.
Australian Examination Report No. 1 corresponding to AU 2014200584 dated Jun. 15, 2015.
European Office Action corresponding to EP 13 180 881.8 dated Jun. 19, 2015.
European Office Action corresponding to EP 14 157 195.0 dated Jul. 2, 2015.
Extended European Search Report corresponding to EP 12 19 6902.6 dated Aug. 6, 2015.
Extended European Search Report corresponding to EP 14 15 2060.1 dated Aug. 14, 2015.
Chinese Office Action corresponding to CN 201210129787.2 dated Aug. 24, 2015.
Chinese Notification of Reexamination corresponding to CN 201010517292.8 dated Jun. 2, 2015.
Japanese Office Action corresponding to JP 2014-216989 dated Sep. 11, 2015.
Canadian First Office Action corresponding to CA 2,686,105 dated Sep. 17, 2015.
Japanese Office Action corresponding to JP 2012-040188 dated Oct. 21, 2015.
European Communication corresponding to EP 13 17 6895.4 dated Nov. 5, 2015.
Chinese First Office Action corresponding to CN 201210544552 dated Nov. 23, 2015.
Chinese First Office Action corresponding to CN 201210545228 dated Nov. 30, 2015.
Extended European Search Report corresponding to EP 15 18 0491.1 dated Dec. 9, 2015.
Extended European Search Report corresponding to EP 15 18 3819.0 dated Dec. 11, 2015.
Canadian Office Action corresponding to CA 2,697,819 dated Jan. 6, 2016.
Canadian Office Action corresponding to CA 2,696,419 dated Jan. 14, 2016.
European Office Action corresponding to EP 12 19 8776.2 dated Jan. 19, 2016.
Extended European Search Report corresponding to EP 15 17 4146.9 dated Jan. 20, 2016.
Chinese First Office Action corresponding to CN 201310353628.5 dated Jan. 25, 2016.
Extended European Search Report corresponding to EP 12 19 6912.5 dated Feb. 1, 2016.
Japanese Office Action corresponding to JP 2012-098903 dated Feb. 22, 2016.
Extended European Search Report corresponding to EP 12 19 8753.1 dated Feb. 24, 2016.
Chinese First Office Action corresponding to CN 201410449019.4 dated Mar. 30, 2016.
Extended European Search Report corresponding to EP 16 15 0232.3 dated Apr. 12, 2016.
European Office Action corresponding to EP 11 18 3256.4 dated Apr. 20, 2016.
Australian Examination Report No. 1 corresponding to AU 2012244169 dated May 10, 2016.
European Office Action corresponding to EP 10 25 0715.9 dated May 12, 2016.
Chinese First Office Action corresponding to CN 201410778512.0 dated May 13, 2016.
Australian Examination Report No. 1 corresponding to AU 2012227358 dated May 16, 2016.
Japanese Office Action corresponding to JP 2012-040188 dated May 17, 2016.
Australian Examination Report No. 1 corresponding to AU 2012244380 dated May 20, 2016.
Australian Examination Report No. 1 corresponding to AU 2014227480 dated May 21, 2016.
Australian Examination Report No. 1 corresponding to AU 2012254977 dated May 30, 2016.
Extended European Search Report corresponding to EP 13 18 2911.1, completed Dec. 2, 2013 and dated Dec. 16, 2013; (8 pp).
Extended European Search Report corresponding to EP 10 25 1795.0, completed Dec. 11, 2013 and dated Dec. 20, 2013; (6 pp).
Extended European Search Report corresponding to EP 13 18 7911.6, completed Jan. 22, 2014 and dated Jan. 31, 2014; (8 pp).
Extended European Search Report corresponding to EP 13 19 2111.6, completed Feb. 13, 2014 and dated Feb. 27, 2014; (10 pp).
Extended European Search Report corresponding to EP 13 19 5919.9, completed Feb. 10, 2014 and dated Mar. 3, 2014; (7 pp).
Extended European Search Report corresponding to EP 08 72 6500.5, completed Feb. 20, 2014 and dated Mar. 3, 2014; (7 pp).
Extended European Search Report corresponding to EP 13 19 5019.8, completed Mar. 14, 2014 and dated Mar. 24, 2014; (7 pp).
Extended European Search Report corresponding to EP 13 19 6816.6, completed Mar. 28, 2014 and dated Apr. 9, 2014; (9 pp).
Extended European Search Report corresponding to EP 13 19 7958.5, completed Apr. 4, 2014 and dated Apr. 15, 2014; (8 pp).
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Jun. 16, 2014; (5 pp).
Extended European Search Report corresponding to EP 14 15 7195.0, completed Jun. 5, 2014 and dated Jun. 18, 2014; (9 pp).
Extended European Search Report corresponding to EP 14 15 6342.9, completed Jul. 22, 2014 and dated Jul. 29, 2014; (8 pp).
Canadian Office Action corresponding to CA 2,665,206 dated Nov. 19, 2013.
Chinese First Office Action corresponding to Patent Application CN 201410588811.8 dated Dec. 5, 2017.
European Office Action corresponding to Patent Application EP 16 16 6367.9 dated Dec. 11, 2017.
Chinese First Office Action corresponding to Patent Application CN 201610279682.3 dated Jan. 10, 2018.
Japanese Office Action corresponding to Patent Application JP 2013-154561 dated Jan. 15, 2018.
Australian Examination Report No. 1 corresponding to Patent Application AU 2017225037 dated Jan. 23, 2018.
Japanese Office Action corresponding to Patent Application JP 2013-229471 dated May 1, 2018.
Canadian Office Action corresponding to Patent Application CA 2,790,743 dated May 14, 2018.
European Office Action corresponding to Patent Application EP 14 15 7195.0 dated Jun. 12, 2018.
Related Publications (1)
Number Date Country
20180214147 A1 Aug 2018 US
Provisional Applications (1)
Number Date Country
61684846 Aug 2012 US
Continuations (1)
Number Date Country
Parent 13942822 Jul 2013 US
Child 15939535 US